ࡱ> WYRSTUV'` ؉bjbjLULU =.?.?*p p p p p p p  HtHtHt8t\t, xww"6w6w6wxxx$hntp x"x p p 6w6w2ڌڌڌ Xp 6wp 6wڌ ڌڌJí\p p 6ww ԩ$_nHtd FkH0xetp xD{ڌ|L ~xxxxxxx iHt Ht p p p p p p   CHAPTER 20 LABELING MEDICATIONS AND EXPIRATION DATING HOSPITAL LABELING IN THE HOSPITAL Standard of Practice in Hospital Unit Dose Medications Studies in 1960s documented reduction in medication errors by 60% Joint Commission requires: a standardized method of labeling to minimize errors label the container if prepared but not administered immediately 1. UNIT DOSE MEDICATION (Prepackaging) reference 64F-12.006 Name of drug (brand or generic or both), Strength Dosage Form Manufacturer Lot number Expiration date/beyond use date OR instead of (d) and (e) a control number which cross references to the manufacturer name and lot number 2. INTRAVENOUS ADMIXTURES ( & Standard of Practice) Medications are labeled at minimum with: Medication name Strength Amount (if not apparent from container) Expiration date when not used within 24 hours Expiration time when expiration occurs in less than 24 hours Compounded IV admixtures and TPN solutions include date prepared and diluent Medications prepared for multiple patients or when the person preparing the medication is not the person administering the medication the label must include: Patient name Patient location Appropriate accessory and supplemental labeling (such as refrigerate) The initials of the person preparing each compound Placement of labels Affixed to containers so that they may be read while hanging The name, type of solution and manufacturers lot number should be visible Placed so that visible inspection of the infusion contents is possible BULK or multi-dose items such as EENTT products (standard of practice) Patient name Room number Pharmacists initials Date dispensed Expiration date/beyond use date, if required All syringes and medication containers are labeled on and off sterile field (National Patient Safety Goal 3D) a) Minimum labeling: name strength amount (if not apparent from container expiration date if not used within 24 hours expiration time when expiration occurs in less than 24 hours Visually and verbally verified by 2 qualified individuals when person preparing is not the person administering the medication only one medication is labeled at a time original containers are saved and discarded at the conclusion of the procedure any containers found unlabeled are immediately discarded at shift or break change medications are reviewed and confirmed by the exiting and entering personnel MAINTAIN IN P&P MANUAL HOSPITAL EXPIRATION DATING PREPACKAGE versus REPACKAGE Beyond Use (Expiration Dates) Reference: 1 USP Revised Standards for Product Dating, First Supplement to USP24th rev + NF 19th ed 2 Okeke CC, Bailey L, Medwich T, Grady LT. Revised USP standards for product dating, packaging, and temperature monitoring. Am J Health-Sys Pharm 2000, (57): 1441-5. Differentiation between expiration date and beyond use date Expiration date scientifically determined Beyond use date for prescriptions or repackaged drug Prescription vial beyond use date The manufacturers expiration date or One year from the date dispensed, whatever is earlier Appropriate to limit how long a patient can retain a prescription after dispensed Repackaging non-sterile oral and liquid dosage forms packaged in unit dose containers One year unless stability data or manufacturer labeling indicates otherwise All other dosage forms = 1 year ASSUMES the pharmacy follows USP/NF repackaging methods, uses appropriate containers, and the container is stored at controlled room temperature (68-77 F or 20-25 C). Measure temperature weekly If temp consistently < 25 C, no calculations need to be done (use 1 year beyond use date) If not consistently < 25 C, use formula to calculate mean kinetic temperature (VERY COMPLEX) Containers evaluate material used and moisture permeability PVC NOT recommended very moisture permeable Check with manufacture of container Packaging systems with 2 or more dosage forms in the same container dispensed to a specified patient 60 day beyond use date once dispensed, can not returned to stock or reused Non-sterile Multi dose containers Manufacturers expiration date unless otherwise specified by manufacturer IV Therapy multidose injectable containers 28 days unless otherwise specified by manufacturer single dose injectable containers (bags, syringes, vials) opened or needle-punctured - 1 hour single dose injectable container opened or needle punctured in LAF hood - 6 hours ampules immediate use only (NO reuse) Low risk Medium Risk High Risk Room Temp 48 hrs 30 hrs 24 hrs Refrigeration 14 days 9 days 3 days Frozen 45 days 45 days 45 days Warmers < or = 104 F - Drugs or IV solutions stored in warmers check with manufacturer on maximum temperature and beyond use dating IVs out of overwrap follow manufacturers beyond use dating Check for Outdated drugs Minimum every 4 months Place in Quarantine Area to prevent mix-up Use of Reverse Distributor EPA pharmaceutical Waste Generator Methods Annual inventory Monthly inspections At time of order Additional Places to Check Crash carts Emergency Dept Operating Room Nursing Units Respiratory Therapy Radiology 64B16-28.108 All Permits - Labels and Labeling of Medicinal Drugs. Each container of medicinal drugs dispensed shall have a label or shall be accompanied by labeling. (1) Definitions. (a) Controlled substance means any substance named or described in Schedules II-V of Section 893.03, F.S. (b) Customized medication package means a package that: 1. Is prepared by a pharmacist for a specific patient. 2. Is a series of containers. 3. Contains two (2) or more solid oral dosage forms. (c) Labeling means a label or other written, printed, or graphic material upon an agent or product or any of its containers, wrappers, drug carts, or compartments thereof, as well as a medication administration record (MAR) if a medication administration record is an integral part of the unit dose system. (d) Radiopharmaceutical means any substance defined as a drug in section 201(g)(1) of the Federal Food, Drug and Cosmetic Act which exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any of those drugs intended to be made radioactive. This includes nonradioactive reagent kits and nuclide generators which are intended to be used in the preparation of any such substance, but does not include drugs which are carbon-containing compounds or potassium-containing compounds or potassium-containing salts which contain trace quantities of naturally occurring radionuclides. (e) Serial number means a prescription number or other unique number by which a particular prescription or drug package can be identified. (2) The label affixed to each container dispensed to a patient shall include: (a) Name and address of the pharmacy. (b) Date of dispensing. (c) Serial number. (d) Name of the patient or, if the patient is an animal, the name of the owner and the species of animal. (e) Name of the prescriber. (f) Name of the drug dispensed (except where the prescribing practitioner specifically requests that the name is to be withheld). (g) Directions for use. (h) Expiration date. (i) If the medicinal drug is a controlled substance, a warning that it is a crime to transfer the drug to another person. (3) The label on the immediate container of a repackaged product or a multiple unit prepackaged drug product shall include: (a) Brand or generic name. (b) Strength. (c) Dosage form. (d) Name of the manufacturer. (e) Expiration date. (f) Lot number: 1. Manufacturers lot number, or 2. Number assigned by the dispenser or repackager which references the manufacturers lot number. (4) A medicinal drug dispensed in a unit dose system by a pharmacist shall be accompanied by labeling. The requirement will be satisfied if, to the extent not included on the label, the unit dose system indicates clearly the name of the resident or patient, the prescription number or other means utilized for readily retrieving the medication order, the directions for use, and the prescribers name. (5) A unit dose system shall provide a method for the separation and identification of drugs for the individual resident or patient. (6) A customized patient medication package may be utilized if: (a) The consent of the patient or the patients agent has been secured, and (b) The label includes: 1. Name, address and telephone number of the pharmacy. 2. Serial number for the customized medication package and a separate serial number for each medicinal drug dispensed. 3. Date of preparation of the customized patient medication package. 4. Patients name. 5. Name of each prescriber. 6. Directions for use and any cautionary statements required for each medicinal drug. 7. Storage instructions. 8. Name, strength, quantity and physical description of each drug product. 9. A beyond use date that is not more than 60 days from the date of preparation of the customized patient medication package but shall not be later than any appropriate beyond use date for any medicinal drug included in the customized patient medication package. (c) The customized patient medication package can be separated into individual medicinal drug containers, then each container shall identify the medicinal drug product contained. (7) The label affixed to the immediate outer container shield of a radiopharmaceutical shall include: (a) Name and address of the pharmacy. (b) Name of the prescriber. (c) Date of the original dispensing. (d) The standard radiation symbol. (e) The words Caution Radioactive Material. (f) Name of the procedure. (g) Prescription order number. (h) Radionuclide and chemical form. (i) Amount of radioactivity and the calibration date and time. (j) Expiration date and time. (k) If a liquid, the volume. (l) If a solid, the number of items or weight. (m) If a gas, the number of ampules or vials. (n) Molybdenum 99 content to the United States Pharmacopeia (UPS) limits. (o) Name of the patient or the words Physicians Use Only. (8) The label affixed to the immediate inner container of a radiopharmaceutical to be distributed shall include: (a) The standard radiation symbol. (b) The words Caution Radioactive Material. (c) Radionuclide and chemical form. (d) Name of the procedure. (e) Prescription order number of the radiopharmaceutical. (f) Name of the pharmacy. (9) The labeling on a carton or package containing a medicinal drug or product dispensed from an Extended Scope Renal Dialysis (ESRD) pharmacy shall include: (a) Use as Directed statement. (b) The name and address of the person to whom the products will be delivered. (c) Name of the prescriber. (d) Name and address of the ESRD pharmacy location from which the products were shipped. (e) Prescription number. (f) Any special instructions regarding delivery dates or locations. (g) Beyond use date or, if the medicinal drug or product is dispensed in an unopened sealed package, the manufacturers expiration date. Specific Authority 465.005, 465.022 FS. Law Implemented 465.022(1) FS. HistoryAmended 5-19-72, Repromulgated 12-18-74, Amended 10-10-78, 9-18-84, 1-20-85, Formerly 21S-1.13, Amended 10-2-88, Formerly 21S-1.013, Amended 7-31-91, 10-1-92, 4-19-93, 7-12-93, Formerly 21S-28.108, 61F10-28.108, 59X-28.108, Amended 3-31-05. NURSING HOME LABELING IN THE NURSING HOME 1. Traditional system in the Nursing Home a. Name and address of pharmacy b. Name of prescriber c. Name of the resident d. Date (original or refill date) e. RX number f. Directions g. Control drug requires transfer warning h. Name of the medication - Brand name, Generic name or both (MD may request to be withheld in the retail pharmacy). I. Quantity (not required in the retail pharmacy) (State) j. Expiration date k. Strength 2. Unit dose system in the Nursing Home ( additional labeling requirements) a. Name (Brand name, Generic name or both) b. Manufacturer c. Lot number d. Strength of drug (Federal regulation) e. Dosage form f. Expiration Date 3. Small Containers a. Ophthalmic Ointments and Drops b. Insulin Vials c. Ampules 4. Floor Stock a. Open Dates on floor stock containers b. Non-Drug supplies  Ex. Tape Bandages 5. Products with abbreviated discard dates a. General pharmacy policies b. Products with established discard dates on manufacturers packaging (see page 20.18 & 20.19) 6. Required Policies and Procedures: a. Reviewing MARs for directions b. Expiration dates c. Returning non-control U/D for credit d. Identifying manufacturers e. Re-labeling soiled or inaccurate labels f. Abbreviations on labels Labeling non-RX stock drugs Labeling products with outer-covers (i.e. IV bags) Labeling products too small for a traditional RX label Expiration Dates in the Nursing Home I. What drugs need expiration dates? 1. All drugs in the nursing home must have a beyond use date. 2. Unit dosed medication (unless direct from the manufacturer) should not exceed 1 year from package date 3. Bulk containers (ex Multivitamins) the manufacturers expiration date may be used unless the facility policy shortens this date 4. Ophthalmics, Otics, Ointments manufacturers expiration date unless facility policy shortens this date II. Who should check dating? 1. Nursing staff should be trained to routinely check expiration dates as part of their med pass responsibility 2. The Consultant Pharmacist should be checking expiration dates during his/her monthly inspection III. Policy regarding nursing checking expiration dates 1. Nursing staff should be required to do a formal review of expiration dates at least monthly. The 3rd shift is an ideal time to do this inspection. Nursing policies should address this Q.A. function 2. Consultant Pharmacist should check expiration dates during the physical inspection each month Pharmacy policies should address the role of the Consultant Pharmacist IV. Document Inspections 1. Both nursing and the Consultant Pharmacist should document and sign their inspection reports 2. The Consultant Pharmacist usually incorporates this inspection document in their monthly report to the Director of Nursing VI. Repackaging - not prepared for direct dispensing to patient 1. Repackaging refers to unit dosing product that will be distributed to another pharmacy for distribution. 2. Repackaging medication does not fall under a Pharmacy permit. A company that wishes to repackage medications must be licensed by the FDA and the Florida Dept of Health as a Repackager 3. FDA good manufacturing standards require that repackaged medications have a MAXIMUM expiration date of 6 months unless stability testing has been completed. VII. Pre-packaging - dispensing to the patient 1. Pre-packaging is what most Pharmacies do. The product can be pre-packaged and immediately dispensed to a patient or the pre-packaged medication can be prepared and stored in the pharmacy for future dispensing 2. Pre-packaged medication should have a MAXIMUM expiration date of 1 year from the date packaged NURSING HOME State Survey Manual 59A-4.112 (5) Drugs and biologicals used in the facility shall be labeled in accordance with currently accepted professional principles, Chapter 499, F.S. and Chapter 61F10, F.A.C. 59A-4.112 (10) The facility shall maintain an Emergency Medication Kit, the contents of which shall be determined in consultation with the Medical Director, Director of Nursing and Pharmacist, and it shall be in accordance with facility policies and procedures. The kit shall be readily available and shall be kept sealed. All items in the kit shall be properly labeled. The facility shall maintain an accurate log of receipt and disposition of each item in the Emergency Medication Kit. An inventory of the contents of the Emergency Medication Kit shall be attached to the outside of the kit. If the seal is broken, the kit must be resealed the next business day after use. Federal Survey Manual F431 (Revised 9/20/2006) 483.60(d) Labeling of Drugs and Biologicals Drugs and biologicals used in the facility must be labeled in accordance with currently accepted professional principles, and include the appropriate accessory and cautionary instructions, and the expiration date when applicable. 483.60(e) Storage of Drugs and Biologicals (1) In accordance with State and Federal laws, the facility must store all drugs and biologicals in locked compartments under proper temperature controls, and permit only authorized personnel to have access to the keys. (2) The facility must provide separately locked, permanently affixed compartments for storage of controlled drugs listed in Schedule II of the Comprehensive Drug Abuse Prevention and Control Act of 1976 and other drugs subject to abuse, except when the facility uses single unit package drug distribution systems in which the quantity stored is minimal and a missing dose can be readily detected. FLORIDA STATUTE 465.0255 Expiration date of medicinal drugs; display; related use and storage instructions.-- (1)The manufacturer, repackager, or other distributor of any medicinal drug shall display the expiration date of each drug in a readable fashion on the container and on its packaging. The term "readable" means conspicuous and bold. (2)Each pharmacist for a community pharmacy dispensing medicinal drugs and each practitioner dispensing medicinal drugs on an outpatient basis shall display on the outside of the container of each medicinal drug dispensed, or in other written form delivered to the purchaser: (a)The expiration date when provided by the manufacturer, repackager, or other distribution of the drug; or (b)An earlier beyond-use date for expiration, which may be up to 1 year after the date of dispensing. The dispensing pharmacist or practitioner must provide information concerning the expiration date to the purchaser upon request and must provide appropriate instructions regarding the proper use and storage of the drug. (3)This section does not impose liability on the dispensing pharmacist or practitioner for damages related to, or caused by, a medicinal drug that loses its effectiveness prior to the expiration date displayed by the dispensing pharmacist or practitioner. (4)The provisions of this section are intended to notify the patient receiving a medicinal drug of the information required by this section, and the dispensing pharmacist or practitioner shall not be liable for the patient's failure to heed such notice or to follow the instructions for storage. EXPIRATION DATES FOR DRUGS AND BIOLOGICALSThe following list represents revised recommendations based on manufacturer's literature or USP standards for expiration dating.PRODUCTEXPIRATION DATEGeneralExternal medications, bulk liquids and solid dosage formsSee manufacturer's containerNitroglycerin sublingual productsNitrostat & NitroQuick - manufacturer's expiration date or 12 months after open datePrepackaged unit dose medicationSee package (maximum 1 year from package date)Do Not RefrigerateSuppositories Store at room temperature unless specifically directed to refrigeratePepcid Suspension30 days from mixed datedStore in RefrigeratorAll Insulin products Good refrigerated for 28 days after open dateAtivan (Lorazepam) injectableGood unrefrigerated for 14 daysAtivan (Lorazepam) Intensol SolutionGood unrefrigerated for 30 days, 90 days if refrigeratedCalcimar InjectionGood unrefrigerated for 48 hoursEpogen & ProcritGood unrefrigerated for 14 days - 21 days after initial entry if refrigeratedInsulin (Novolin)Good unrefrigerated for 28 days after first useMiacalcin SprayGood unrefrigerated for 30 days - store uprightPepcid InjectionGood unrefrigerated for 7 daysPhospholine Iodide OphthalmicGood Unrefrigerated for 30 daysVentolin nebules 3mlGood unrefrigerated for 14 daysXalatan Ophthalmic - until openedGood unrefrigerated for 6 weeks - protect from lightIntravenous ProductsAll Piggy Back IV solutions 100cc or below15 days after removal from outer cover (if not spiked)All Piggy Back IV solutions 1000cc30 days after removal from outer cover (if not spiked)All mixed medications for infusionrefer to expiration date provided by pharmacySolutions for IrrigationAcetic acid for irrigation24 hours after openingGCP Solution30 days after mixing (refrigerate)Sterile normal saline for irrigation24 hours after openingSterile water for irrigation24 hours after openingOphthalmics, Otics and Inhaled ProductsAdvair DiscusDiscard 1 month after removal from the protective overwrapDuo-NebProtect from light, store in foil overwrap. Discard after expiration dateFloventDiscard 6 weeks after removal from moisture protective overwrap pouchForadil 4 months after open date or product expiration date (whichever is earlier)SereventDiscard 6 weeks after removal from moisture protective overwrap pouchEar DropsManufacturer's expiration dateInhalersManufacturer's expiration dateMiacalcin Nasal SprayOnce opened, store upright at room temp for up to 35 daysMucomyst (acetylcysteine)96 hours after opening if refrigeratedOphthalmic Solutions & OintmentsManufacturer's expiration dateNasal Sprays Manufacturer's expiration datePhospholine Iodide Ophthamic6 months after pharmacy reconstitutionVentolin inhalation solution 0.5% 5mg/ml x 20ml28 days after open dateXopenexStore unopened vials in foil pouch, use within 2 weeks after pouch is opened, use indivisual vials withing 1 week after openingMiscellaneous ProductsAll Multi Dose Injectables28 days after open dateAmpulessingle dose onlyAranespsingle dose onlyB Complex with C & B12 Injection14 days after reconstitution (must be refrigerated)Bacteriostatic Normal Saline28 days after open dateBacteriostatic water for injection28 days after open dateEmergency BoxMust be replaced next work day after openingLasix (Furosemide) Oral Solution60 days from open dateMorphine Sulfate Soln (Roxanol)90 days from open dateSingle dose vials and dosettes24 hoursSterile water for injectionOne time use onlyTubersol (or Aplisol) tuberculin PPD for original vial (28 days) after opening (refrigerated) PHARMACY REGULATIONS 64B16-28.108 All Permits - Labels and Labeling of Medicinal Drugs. Each container of medicinal drugs dispensed shall have a label or shall be accompanied by labeling. (1) Definitions. (a) Controlled substance means any substance named or described in Schedules II-V of Section 893.03, F.S. (b) Customized medication package means a package that: 1. Is prepared by a pharmacist for a specific patient. 2. Is a series of containers. 3. Contains two (2) or more solid oral dosage forms. (c) Labeling means a label or other written, printed, or graphic material upon an agent or product or any of its containers, wrappers, drug carts, or compartments thereof, as well as a medication administration record (MAR) if a medication administration record is an integral part of the unit dose system. (d) Radiopharmaceutical means any substance defined as a drug in section 201(g)(1) of the Federal Food, Drug and Cosmetic Act which exhibits spontaneous disintegration of unstable nuclei with the emission of nuclear particles or photons and includes any of those drugs intended to be made radioactive. This includes nonradioactive reagent kits and nuclide generators which are intended to be used in the preparation of any such substance, but does not include drugs which are carbon-containing compounds or potassium-containing compounds or potassium-containing salts which contain trace quantities of naturally occurring radionuclides. (e) Serial number means a prescription number or other unique number by which a particular prescription or drug package can be identified. (2) The label affixed to each container dispensed to a patient shall include: (a) Name and address of the pharmacy. (b) Date of dispensing. (c) Serial number. (d) Name of the patient or, if the patient is an animal, the name of the owner and the species of animal. (e) Name of the prescriber. (f) Name of the drug dispensed (except where the prescribing practitioner specifically requests that the name is to be withheld). (g) Directions for use. (h) Expiration date. (i) If the medicinal drug is a controlled substance, a warning that it is a crime to transfer the drug to another person. (3) The label on the immediate container of a repackaged product or a multiple unit prepackaged drug product shall include: (a) Brand or generic name. (b) Strength. (c) Dosage form. (d) Name of the manufacturer. (e) Expiration date. (f) Lot number: 1. Manufacturers lot number, or 2. Number assigned by the dispenser or repackager which references the manufacturers lot number. (4) A medicinal drug dispensed in a unit dose system by a pharmacist shall be accompanied by labeling. The requirement will be satisfied if, to the extent not included on the label, the unit dose system indicates clearly the name of the resident or patient, the prescription number or other means utilized for readily retrieving the medication order, the directions for use, and the prescribers name. (5) A unit dose system shall provide a method for the separation and identification of drugs for the individual resident or patient. (6) A customized patient medication package may be utilized if: (a) The consent of the patient or the patients agent has been secured, and (b) The label includes: 1. Name, address and telephone number of the pharmacy. 2. Serial number for the customized medication package and a separate serial number for each medicinal drug dispensed. 3. Date of preparation of the customized patient medication package. 4. Patients name. 5. Name of each prescriber. 6. Directions for use and any cautionary statements required for each medicinal drug. 7. Storage instructions. 8. Name, strength, quantity and physical description of each drug product. 9. A beyond use date that is not more than 60 days from the date of preparation of the customized patient medication package but shall not be later than any appropriate beyond use date for any medicinal drug included in the customized patient medication package. (c) The customized patient medication package can be separated into individual medicinal drug containers, then each container shall identify the medicinal drug product contained. (7) The label affixed to the immediate outer container shield of a radiopharmaceutical shall include: (a) Name and address of the pharmacy. (b) Name of the prescriber. (c) Date of the original dispensing. (d) The standard radiation symbol. (e) The words Caution Radioactive Material. (f) Name of the procedure. (g) Prescription order number. (h) Radionuclide and chemical form. (i) Amount of radioactivity and the calibration date and time. (j) Expiration date and time. (k) If a liquid, the volume. (l) If a solid, the number of items or weight. (m) If a gas, the number of ampules or vials. (n) Molybdenum 99 content to the United States Pharmacopeia (USP) limits. (o) Name of the patient or the words Physicians Use Only. (8) The label affixed to the immediate inner container of a radiopharmaceutical to be distributed shall include: (a) The standard radiation symbol. (b) The words Caution Radioactive Material. (c) Radionuclide and chemical form. (d) Name of the procedure. (e) Prescription order number of the radiopharmaceutical. (f) Name of the pharmacy. (9) The labeling on a carton or package containing a medicinal drug or product dispensed from an Extended Scope Renal Dialysis (ESRD) pharmacy shall include: (a) Use as Directed statement. (b) The name and address of the person to whom the products will be delivered. (c) Name of the prescriber. (d) Name and address of the ESRD pharmacy location from which the products were shipped. (e) Prescription number. (f) Any special instructions regarding delivery dates or locations. (g) Beyond use date or, if the medicinal drug or product is dispensed in an unopened sealed package, the manufacturers expiration date. Specific Authority 465.005, 465.022 FS. Law Implemented 465.022(1) FS. HistoryAmended 5-19-72, Repromulgated 12-18-74, Amended 10-10-78, 9-18-84, 1-20-85, Formerly 21S-1.13, Amended 10-2-88, Formerly 21S-1.013, Amended 7-31-91, 10-1-92, 4-19-93, 7-12-93, Formerly 21S-28.108, 61F10-28.108, 59X-28.108, Amended 3-31-05. NURSING HOME SAMPLE POLICY & METHODS Medication Labels POLICY: All prescription drugs are to be labeled in accordance with federal and state laws governing prescription dispensing, and in accordance with standards of pharmacy practice. No person other than the pharmacist is to modify any prescription label. Non-prescription drugs are to be kept and stored in the manufacturers original container and identified with the patients name. The nurse receiving the drug is responsible for assuring that all drugs coming from the pharmacy are properly labeled. METHODS: 1. The licensed nurse receiving medication is responsible for assuring that each item, regardless of which pharmacy supplies it, is properly labeled in accordance with the following procedures. Any drug improperly labeled is to be rejected and returned to the pharmacy which issued it. 2. Labels are to be permanently affixed to the outside of the prescription container. Under no circumstances should medicine be accepted by the nurse if the label is inserted into the vial. 3. All prescription medications, regardless of the source, are to be labeled as follows: a. The directions for use, as specifically as possible. b. The name of the patient, first name first. c. The name of the prescriber. d. The date the drug is dispensed. e. The name, address, and telephone number of the issuing pharmacy. f. The prescription number. g. The brand or generic name of the drug. When the generic name is used, the name or an acceptable abbreviation of the manufacturer is to follow. When a generic drug is dispensed in place of a brand name product, the generic name, the name or an abbreviation of the manufacturer, and a statement similar in effect to: h. Strength i. Quantity j. Expiration Date 4. Non-prescription drugs not dispensed by prescription are to be in the manufacturers original container and identified with the patients name. 5. Medication containers having soiled, damaged, incomplete, illegible, or makeshift labels are to be returned to the issuing pharmacy for re-labeling or destroyed in accordance with the procedures for drug destruction. 6. The drug label is not to be altered, modified, or marked in any way resulting in any change in the original meaning, nor are contents to be transferred from one container to another. If the pharmacy makes a typing error on the label, or the directions for use change, the medication should be returned to the pharmacy for re-labeling. 7. Crisco is occasionally ordered as an emulsion and is used for cosmetic purposes of reducing dry skin. Patient families may purchase the Crisco for the patients use and bring the manufactured sealed container to the facility. Crisco may be retained on the treatment cart and labeled by the nurse with the patients name, room number, and date Crisco was brought to the facility. NURSING HOME SAMPLE POLICY & METHODS Checking for Expiration Dating POLICY: It is the policy of this facility that all medications provided to the residents will be of good potency and in good date. METHODS: 1. All medications received into the facility will be of good date and nursing personnel will check the dating when received. Medications received with expired dating will be removed from the facility using the appropriate procedures. 2. The 3 to 11 shift on Mondays will be responsible for checking all medications in the facility for dating. An appropriate log will be kept which identifies which areas of the facility is checked each week and the person responsible for checking. All areas of the facility where drugs are stored will be checked at least monthly. 3. The consultant pharmacist will check for dating on his regular visits. All outdated drugs found will be destroyed or returned to the vendor pharmacy and reported to the director of nursing. The director of nursing will counsel with the nurse responsible for last checking the area in which the drugs were found.     PAGE  20. PAGE 1 &',/0ABCDEST]^wx ƿ񱭦~v~k`Uhl hcbCJaJhChcbCJaJhChCCJaJhCCJaJhl hCCJaJhC5CJ\aJhl hC5CJ\aJhC hC5\hcbhcb5>*\ hsCJ hs5CJ hs5CJ h#-h#-5>*CJ aJ he5>*CJ aJ hj1M5>*CJ aJ h#- h#-h#-hs&'BCDEFGHIJKLMNOPQR$a$$a$$a$gd#-gd#-gd#-׉RT]^wx F gdl$a$gdl & F1$7$8$gdC & FgdC h^`hgdC ^`gdC & F @1$7$8$^gdT$a$gdCgdcb$a$gdcb   @  " + S 1$7$8$^gdC & F1$7$8$gdcb8^8gdcb & F1$7$8$gdcb & F1$7$8$`gdTgdcbgdl & Fgdl & F1$7$8$gdl    ? Z    E F G *+ejcdɾܳɳѳџh|2CJaJhJhcbCJaJhRhcbCJ hcbCJhChcb5>*CJaJhxhcbCJaJhl hCCJaJhcbCJaJhl hcbCJaJhxhcbCJaJhcb5CJ\aJhh+hcb5CJ\aJ/   F G [ *+r & F 1$7$8$gdcb & F 01$7$8$^`0gdcbgdcb^gdcb8^8gdcb & F1$7$8$gdcb & F1$7$8$gdcbOejs3 & F1$7$8$gdcb & F1$7$8$gdcb$$ & F-D7$8$M ]a$gdcb^gdcb$$$ 0-D7$8$M ]^`0a$gdcbgdcb67Wdde & Fgdcb$a$gdcb$a$gdcbgdcbgdcb$$ h-D7$8$M ]a$gdcbdefcd,23{| a    $%.౤|̄qhJh/CJaJh=wWCJaJh/CJaJhJhcb>*CJaJhJhcb5CJaJhcb5CJOJQJaJhJhcb5CJOJQJaJhJh|2CJaJhcbCJaJhJhcbCJH*aJhJhcbCJaJh|2CJaJh|2h|2CJH*aJ),R3GbX & F ^gdT & Fgdcb8^8gd=wW & F 8^8gdTgdcb & F 8^8gdT & F gdcb & F h88^8gdT & F gdcb & F h88^8gdT+`a.     hgdcb & F hgdT & Fgdcb$a$gdcb$a$gdcbgdcb & F^gdT & F^gdT & Fgdcbh^hgdcb & F ^gdT /Qw"#abc|} /@ & F h^gdTh^hgdcb & F h^gdT & Fgdcb$a$gdcbgdcb8^8gdcb hgdcb#7acA\344455A6u66ûòãßzgSLHCHCH hS*5hS* hS*5>*'ho]hl6B*CJmHnHphu$ho]hlB*CJmHnHphu'ho]hl5B*CJmHnHphu!h/5B*CJmHnHphuh fhJhcbCJOJQJaJhRhcbCJhCCJaJhJhcbCJaJhl5>*CJaJhcA3hcb5>*CJaJhcb5>*CJaJhJhcb5>*CJaJ@A\hw]$$d1$5$7$8$9DH$a$gdl"$$ hhhhhd1$5$7$8$9DH$`ha$gd/"$$ hhhhhd1$5$7$8$9DH$`ha$gdl & Fgd< & F`gdT & Fgdcbgdcb ]nKiR""-#S#k#~##$$$$-%%%%%&& $ hhhhhd1$5$7$8$9DH$`ha$gdl&&&G&&;(()L)d))*W*j****@+G,,`-----.3. $ hhhhhd1$5$7$8$9DH$`ha$gdl3.R.v..../M///E0h00001)11172S222 33 $ hhhhhd1$5$7$8$9DH$`ha$gdl34444444444444444444444444$dd1$5$7$8$9DH$a$gdl444555@5A5a5w55555546x666667 7 0^`0gdS*`gdS*gdS*@&gdS*$a$gdS*gdS*@&gdS*$a$gdS*6678P8f8g88888999::;G;<<<<<<8=9=c=@>A>>>>`?? @#@G@AABAA\CdCCCCEEE E!Eʧʛʧʧʧʏʅʅ hS*>*h%|Wh0Q46CJh%|Wh0Q46>*CJh6h0Q46CJH*h6h0Q46CJ h0Q4CJh#-h0Q4CJh#-h0Q46CJ h0Q46CJ h0Q45\h0Q4jhLUmHnHuhLh62hj1MhS* hS*51 7K7[7i77777777 8 88P8f88888888888888gdS*`gdS*88888 9Q9999999:%:P:k:::::::;;$a$gd0Q4@&gd0Q4 & FgdS*`gdS*@&gdS*gdS*;;;G;; <<<7=9=Z==A>B>}>>`??#@$@?@@ ABACAAAoB gd0Q4gd0Q4$a$gd0Q4oBBECCCC:DDEE!E.E/E0E1EEEFEEEHHH^gdS*gdS*@&gdS*$a$gdS* $@&a$gdS*gdj1Mgd0Q4!E.E1EEEFECGqGHHHHHHHIIIIIJJJ@LLLLLLLĸvbP#h#hS*5B*CJ\aJph&h#hS*5CJOJQJ\^JaJhRhS*5aJhRhS*@B*aJphhRhS*@B*aJph hRhS*5@B*aJphhS*5@aJhRhS*5@aJhS*5@B*aJph hRhS*5@B*aJph hS*5hihS*>*hS* hS*>* hS*5>*HHIIUIIJJJJfPd1$7$8$H$]^gdS*$d1$7$8$H$]^a$gdS*$d1$7$8$H$^a$gdS*d1$7$8$H$^gdS*$Hd1$7$8$H$]H^a$gdS*d-1$7$8$H$^gdS*d1$7$8$H$^gdS*d1$7$8$H$^gdS* JLLLLLLMNmOPQRRRRRRRRRgdS*$a$gdS*p7$8$H$^p`gdS*$a$gdS*gdS*^gdS*d1$7$8$H$]^gdS*LLO>O\OmOrOORRRRSSSSST TTTTTTTUUVUWUUUUUUUUUẲ}thththth\ththth\thhbh 95CJ\h 9CJOJQJ^Jhbh 9CJh 95OJQJ\^Jh 95CJOJQJ\^J h 95CJOJQJ\^JaJh 9B*phh-B*phhS*B*phhS*>*B*CJaJph h"CUhS*>*B*CJaJphh"CUhS*B*CJaJphh#hS*B*CJaJph$RRSSSSS}}$$1$7$8$H$Ifa$Lkd$$If6h0L'>+4 6a$1$7$8$H$Ifgd 9$$1$7$8$H$Ifa$gd 9gdS*SSSSSSSVGG$1$7$8$H$Ifgd 9Lkd$$If6h0L'>+4 6a$$1$7$8$H$Ifa$Lkd$$If6h0L'>+4 6aSSSSSSSVLkd$$If6h0L'>+4 6a$$1$7$8$H$Ifa$Lkd}$$If6+0L'>+4 6aSSSSSTTXII$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a$$1$7$8$H$Ifa$Lkd{$$If6;0L'>+4 6aT TBTTTTTXLkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6aTTTTTTU]NN$$1$7$8$H$Ifa$Jkd$$If60L'>+4 6a $1$7$8$H$IfJkd}$$If60L'>+4 6aUUUVUWUiUUZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkds$$If60L'>+4 6aUUUUUUU]NN$$1$7$8$H$Ifa$Jkd$$If60L'>+4 6a $1$7$8$H$IfJkdi$$If60L'>+4 6aUUUUUV!VZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd_$$If60L'>+4 6aU!V"VVVVVWWXWYWWWWW X X?X@XXXXXXXYYoYpYYYYYYYZZCZDZZZZZZZZZ,[-[[[[[#\$\s\t\\\\\]]Y]Z]]]]] ^^V^W^^^^^^^^^2_3_h 95CJOJQJ\^Jhbh 95CJ\h 9CJOJQJ^Jhbh 9CJR!V"VGVVVVVZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9JkdU$$If60L'>+4 6aVVVWW(WXWZJkd $$If60L'>+4 6a$1$7$8$H$Ifgd 9JkdK $$If60L'>+4 6aXWYWiWWWWWZJkd $$If60L'>+4 6a$1$7$8$H$Ifgd 9JkdA $$If60L'>+4 6aWWW X XX?XZJkd $$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd7 $$If60L'>+4 6a?X@XbXXXXXZNN $1$7$8$H$IfJkd $$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd- $$If60L'>+4 6aXXXXXXYZKK$1$7$8$H$Ifgd 9Jkd $$If60L'>+4 6a$$1$7$8$H$Ifa$Jkd# $$If60L'>+4 6aYY8YoYpYYYZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6aYYYYYYY[LL$$1$7$8$H$Ifa$Lkd$$If6h0L'>+4 6a $1$7$8$H$IfJkd$$If60L'>+4 6aYYYZZ ZCZZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd $$If60L'>+4 6aCZDZiZZZZZZJkdz$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6aZZZZZZZ]NN$$1$7$8$H$Ifa$Jkdp$$If60L'>+4 6a $1$7$8$H$IfJkd$$If60L'>+4 6aZZZ,[-[5[[ZJkdf$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a[[[[[[#\ZJkd\$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a#\$\-\s\t\~\\ZJkdR$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a\\\\\\]ZJkdH$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a]]2]Y]Z]{]]ZJkd>$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a]]]]]] ^ZJkd4$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a ^^>^V^W^_^^ZJkd*$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a^^^^^^^[LL$$1$7$8$H$Ifa$Jkd$$$If60L'>+4 6a $1$7$8$H$IfLkd$$If6+0L'>+4 6a^^^^^_2_]NN$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a $1$7$8$H$IfJkd$$If60L'>+4 6a2_3_;_L_M_U_f_ZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a3_L_M_f_g_____.`/`j`k`````aa3a4aaaaaaaaaaaaaaaaaaaaaaaaaaaaƾhS*5CJOJQJ\^J(h"CUhS*5B*CJOJQJaJph"hS*5B*CJOJQJaJphh 9B*phhS*B*phh 9CJOJQJh 95CJOJQJ\^Jhbh 95CJ\h 9CJOJQJ^Jhbh 9CJ/f_g______ZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6a__`.`/`=`j`ZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkd$$If60L'>+4 6aj`k``````ZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkdw$$If60L'>+4 6a```aa!a3aZJkd$$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkdm$$If60L'>+4 6a3a4a[aaaaaZNN $1$7$8$H$IfJkd $$If60L'>+4 6a$1$7$8$H$Ifgd 9Jkdc $$If60L'>+4 6aaaaaaaa]NN$$1$7$8$H$Ifa$Jkd!$$If60L'>+4 6a $1$7$8$H$IfJkdY!$$If60L'>+4 6aaaaaaaa]Jkd"$$If60L'>+4 6a $1$7$8$H$IfJkdO"$$If60L'>+4 6aaaaaaaa]Jkd#$$If60L'>+4 6a $1$7$8$H$IfJkdE#$$If60L'>+4 6aaaaaaaa]Jkd$$$If60L'>+4 6a $1$7$8$H$IfJkd;$$$If60L'>+4 6aaaaaaaaaa]UPPH$a$gdS*gdS*1$7$8$H$Jkd%$$If60L'>+4 6a $1$7$8$H$IfJkd1%$$If60L'>+4 6aaabtbbb,cccccd\gkgggGhmhhhiiiiiIjJjKjLj 07$8$H$]0gdS* 7$8$H$gdS*aabbbccccggGhiiIjJjSjjkkkkl$lPlQl`mamfmgmmmmmm.nqpppqqttvvxzҶҚҶҨҚth"CUhS*6OJQJ]^JhS*>*OJQJ^JhQ5OJQJ^Jh"CUhS*>*OJQJ^Jh"CUhS*5OJQJ^JhS*5OJQJ^J h"CUhS*hS*OJQJ^Jh"CUhS*OJQJ^J!h"CUhS*5>*OJQJ\^Jh"CUhS*5OJQJ\^J-LjMjNjOjPjQjRjSjjjj k'kvXvvwfwwww8xxxAyyzzzzz*z*hS*5>*\hS*OJQJhhS* hS*5 hS*5>* hS*CJ h"CUhS*-=zEz7|8|A|`}a} ~!~z~{~~~~~'(lm`gdS*gdS* 0^`0gdS*gdS* @&^gdS* 1$@&gdS*ˀ̀؀ـՃփVXef~$a$gdS* $@&a$gdS*$a$gdS* $@&a$gdS*gd0Q4 0^`0gdS* ^`gdS*gdS* p0^p`0gdS*%&/0jk$a$gdS*$a$gdS*$a$gdS* $@&`a$gdS* $@&^a$gdS*gdS*1$@&[$\$gdS*@&gdS*$a$gdS*‰Éĉ҉Չ։׉؉gdS*&`#$(/ =!"#$% n lg;?Qc `VPNG  IHDR60sRGB pHYsnu>IDATx^mU߉+Wz9wV7R+P` ?0a-`3$! Z\rݪ|ks,]=U{9;kG?я|ۿ7D*sȑO|O|V^2v;o_^Z8~ؕWS$gfD>I&zQot{ZN=J|LFGF/]wl6wl&l6Δ^NCknQB!l}rjxWNNNR^NyL$:ұZfaPFsll4_,\:7==E_L'a*NSlxN$t*gzV(WVVnZ /Kfz4Y(z6ctڭv;K0L&3f;X,VUZ]]kѠ@ϨD80Ҷɩ)N贙@/[]]e Z&9Z6S+2DT*W6*3IJV 5Z5À^Oݍ2) LhDǮss4>2fp\.u{=MR_M $srt&R^Y$Ysb5BOz=apc<piih.,e.]Z\i d3kMStt-0Hrr(f'dznlttZn/0֋W N VYcI'0q bzႇAv[oekzfΐU&# iCs%̔nLOjug4.^2h43LFL/)֔yTԺt:TOMd-1za` x3Iv,3k~@Hm| }hJ <Ki& :.6Kg__wz]YHpb<42֞!2zT*'4f2IChHlTZ`mՀ$-8)cs|\k6 aC6eZ[dݦÇ~!:sčtv:<}G2 -v.[suS y3g\|F9MqyyU呑ŹnvZ\\̤3L02S6}6V7XZ:==m4/)BNO2f딖 k.b32Spqj~d5OraHEf.[V?~[ *WkBl.җFy5m }4H B) kkLMLͻv͜:u!orr%'Zemv׮JFXY_r ;\2:6r}=O*+ µkSNVaxz&)UآBD;p_EFZF"ŨYlV(&3,o4{"l! RiD#̅]Z*@fIՆ 4<YFPUڴ.˺ m`0@bp؅0⒐TnTyQlr'RIbr X Xcg7*c#@٨XA-:Bt̂[kX.d4:2)dJ\Mlrc8b P\hǦxkh1X3` ȍ/'U3TZ__-m[ϝ=!a2R*sͮ޷o";ե|>jbCؼL̀mDB괘#bW/})@*x1|X&D'K2]- D#(Ȥ4]/hl5#0kuqLDp d&C?D00+kk4r !DC glDR^SyE1[ ~gs#hKYJ[4bJM9ɯ-lKoV- ؞-{a*@Zsk i+UᵙX__YYeNÇ@,/7\Cv䉧Xl6}ʆBCS.XXn0^8A"elGD%h-$WkSS+ OM-.,H ,I*u`i>bwzfzqᚉG:J'RȭN8aXؽ{vuuy}ᄑ*$:ߪ8w(e{nn%Eh(*Wkkl ** a?|×^|zBQѱK/ę=?My&M,-.,..Z./$L +XwDL-{X`,o&nrj̚ 6=P][VHl&5&FN6F$_M(1!;1K807J?!;vlPkl]pGȟdu-QrZIShJkK H ָ8d3XGm~ (2(h Ճ0$CAm@Yd|ZEə*p ڼ,- F1p23p0b8NJ\>a1TDt5 ӵ y ;p r6{U |lh+0oQ6֪lըJͬ'%SMHRe^-*;j*mT+X<T% +F6:2lH~o?׿v(Xhۗ염60na EOPkT!5EEAcA/׫s $<^ZZ&f!YEpaey {IJ.-R!4µYASl-ɒ6 HIvVUQR*@gTLgX]&ڳ6#":h )NV]> -@qZ1)@ҷ} 9tХ˗QY ‚_ȱfXM#44a54T'DJlRBh2twrҶɌQdpӀELO`Yˣ#u&gڕ(z@$8׵u076 =Bm12c'3 #4{ $h$B#hT3vPcksآxl8\t:,:2&)7&˫.L0r ȗyLfn =W^1-c6MOM+X0$dygbd3-J0׵VXGB ƉCGQ%f߅c6Lmc#7K@ R0DXX.POEX2eH" "|ƵSXJ[yLvjrFE׀]/5#6֊^ 2LCi &aXwr?Lj02*i(~V@.ع>f01ljXSK4M74n Ĉcw} MY&KRX4\%a#&+t3^66*354) M:3'SHeW%6%o0&#,01/FBs‹e*k($ݥE2R. jc?ݯy7R kz{iXφ_Hy|7}j;| NĨ[O'Y_avw-|:2+\dQL٧ٳyunS>8 bCtTbX+l]X‚U!%S=4,l0$@"bOL0ԡVk,/`AbeN`$6\*a_69vK2Ş{ A 9w+ȥ "uGrRkG) tu˥3b_ᠮQAM"1*x\*Bjyt^m  4jFOmB`hwԣ4i5"DX+Lx\ ˗~-Jg &qK /kEW$E1`T0тi 5hEːI&ڒǑhBIXk.^@?&z3ɦ0uFqG\ [\I#W^"0ҐuE<)4$6!`Bp-pMD~U}-,yP(!D抲 `(Cq!ccc}ltL25+n$ ND\^ 4 س {ߴb<7a'ftͲ߽oҒULO +D)RBlb !d;H!g$)6Lgawԕ !c[Td87 (v;httc. N_ȕǣl!O~k'ܛ#}tM!ݖ<w,+Ϻ-Hr@Pq;yLunO asDLJ񬡱&"/z9;bOLB8[SSؒڹtft텥)@6d0b>$zȊi1Yh /,Z"DJ,D aB]^FYF.JP*aGP+aX5;kL !c=Zp'zm=+8AƱ>If Lًp,Xd0-лjp/IB(\.]eH5uxz02TLp&{eWָ_o }4f-&ǓV116arB(PaHkJ&c#Lӟtp`4]H KCpho*F 8}cC_ zlBE?m{iC酖"F'lr s]hιCtmk;P9 N|P?o 'sۣgx8>D#E)j?Rd%F -3ޣȅ*:Qy˼FЋ≳hѬ}΀}Q/w3rğӷƥh㍴6j+rEMB 5' R5XšCG,?LyLVh4+pqx |a&n>|·[02nap<995 eG%"K|iuuTR.[VkXP0K`|TG IU!,c#Dg8(qcQ.1XEf*GE)#PDڐ潼@ cʙ~]1^Jfi+ĕͼ`zT^OrcBџ,|Se(F lCI _4-,@nC;ko~s21hsD-7v"ښ%<{lx8Jߋ}0P>8N8ɋF4L[%ZM_}g6q/Xcو}w,!b>h>PظSGJ3o Lp^ӗ+6H;<>H57:n OKr=tZ}EVtgBY\;xؕ!Nuc,sDSx >>x\3Do ,z"+Dd>qFJ\Fb_H&[d0pR6~s[Ejx^Hʄht"~|]wO_>*z +S_~I Nh bJnWٍPxnAh$ǥIYpE1Bsxr(xpqʶs8:OӇ }-q1YėX%'J# V-D>a >;{^9ox͐~;^km}fYSoOD%:Ĺ4tF75* Lߊl6MD羬mAo-vΥ,a# lFR#Dߡt{9x`EbȠ3r4vqs;;%ʻ5|'hg⃯ /zeǝK#q97>/l e9}˿ 5bYCƙP]$s+ 9b"hb[E_o篗+lAu{8f-p3?4zGmA[>!uaNH!mָG"}$bin*4;IZ՞#z }= ښ:\W}ua7Q\Ğo"?un3-Եv"`x|GĈK~_G8þ_z9VĠw~jW}:i;dNg8n{_[p] gjǨX#wbMszv;i?շ}.z>2m nq>{Fv Mt('-VG\p(?$;5 O~3Npgod l dոi>/!Nv)۶r)݉e"^f;qV4wz R D}^wc-ÛcV>D4Ct8Cu 3Ty Wݡd  F"s8J}Nh+n6¡#{xX=Hn_{m.;Y9p BO;WvuSxlpoAж0*>9e;ċ/=GTx~_vBߍznc~[k;x!`_qF7߾n-e| z[sUnm{iCeپC@do< f7;| ౝs$EŬ,6;'_l qĊFԡmUeTCYQ4A8lvb*b[hCء#[bvYfp av^[p/ྲྀ=he5FnGCPw@" ]0cQ#y2HxYf} VdF}VMxAv'al@|s/+uc0_xx/&H_<\j>Tޚ?Esp: d9wB`[\[͸'NwW&_4ɫuoPVLD/)cWqPl(3T=ٸىu !<a eZCfH~ C!*RCWm芇Sr gQiPn&ěOp[Ya'c{fkk'$5v㞿vM( :ٌ|/Ucq(4:qb|cN:f/~>>5>@ eT!HA/tlL"Â=mlYn18úQ|͞5:}ie;æI>DڤDT|3[P>\D .ohPh(MI;}"NR4ęf 8A o$ql-O-nF[NmG-ǧ?ȁ 6Em6zBc[L ;!A/a_`YI 3ZN{e(ٌ7lN} dx ҦAj' 2w7q0l}7C3xsUA- & rN4-X]Ҏv[c#a. &E./n>V7}Ŀ>P+.GOl;_8 yfٌ3 eqxj0ǁ\[8.I'} ڂNdB\/c;Ght:j Kxs۝vo0>ȋ?`N|':b] umFy7cipY e3-8Yt 8zk[*?f:MDs83Gd CǝALڌ"^aG8Co18(6#?NL3zhGd?}=dh#0E{ED9Q¶n!rw}'h}[4n|at nb _hzGoaa!ַɤD 4aQQvȥ"P%}~3"(O}mG;&Rfu^3&Po6j aߊWf.!~(&i}=G :'N' Ó-fp;n>ЇR-J먝Adp C_H<oDi^ -F7Yi"ngGspxF>O'vvwԧUKk#}O2#T?jK z[+##nGct~lhD@9|2I}F|{h."_qy` 7K7N?RϨ'"F>kՈ!B1a^|Ԣ>D/PuzWaKW0uZ忼gھ+ =ߍD^p?>H\E{qρ;]8|[,$yG3D}F{h}"RW.OWj/u2xy<'sNu^ 4#>;\xfaD7N{5ވX{ 3 m؜@O.|x_h]Z!D|@)8V)z<+QR>}:Jpŋ[ĉwnzECrJr?_Gǹw$,q='賋||޻||Q|q118$7 > hE-FEk}?Mg*yLw>Oqkv,z]pWq ~ϩ*Q]Ш9rq8uJʵC!yxw\Cx;;N|0)S`۔}N} EMTd4 |"&5_7mlU*C0H Yhg"uqgO@2w}>_,G]E܋h3">}yt㒯06}0\8 GxѬ§ƯڥH_gD.xeCkS~*BE4j .~gĿFZډ^ww4D/FV߶ik}OvpN@Μv:wdEq '^+.\'5#onS1'F,Wkwt)tʿz/tj8_z9$< ';-{qj;yr D}<Sw:Ȁah, 'Ut"nʛu[>Bp-RPFBf>_ƣ5k$tx>5)D0'Y҉w`/#OF2#_t9:#GX[z8$Yd4#[4BF콸!z8 )]ԩA>/ĝh }QtՍ6DT/깅KDq^}̉NI@Ip9NaUx n{_œ~'ދ]aK>0X?â/f37Kîx"̝"mw'|A+=DIs[Dqߨv;OǜW9 5.hZȢc|H|'}=!G᷀=D 5i/C#Gcwǁ섒|"%&jЧw|At DOFEoߡ7>8Cá}2@suQ}?d*"N]o) :p-ɢCwޗ|%S.aNkxbrwa/o,ʟw:cfdtFüx7!^,9AQ4 ೋVǁOp_}$*T%x˼tЁk|"vdp8DK> oXdVc+G bu\3/4pȻ;u\ęz|xHn}G>4ݸ $ ,87}8xG'}M>fbheH`i1j*}[&mQ7.^LɏwwM/Pӿ1 NW~~:Sۏ}ЩW= ?\·O>zdh]ί/=hR|©ۦD ;]Dv3fPۭ8b5 gHn34l䯳d;Ccsqux|寳gN#tFޑOYĈDSaީ3 ׈_r+i6.8#wI1ϻAk_삅cضO-_a1aXlo σ(+>h}Î~#hoɧ;>7;KXۮk~ZK~}E\;a>8ztvB!qdЎrr߾qw]G'O|kXG3ZLTJΖ=d'y Ox·|qMxoި/]?B_⯽2)xZkI 4U.&FGS\СOC?D(\|}.Izߖ'SŒ^&{k:O 6G+ YT׬uѯ~Ǜ|Ϸ+O.eK GΝśtXzt4&wj\,ΟfE>񉿸2w*_L0B1Q(%ٟ=xp_{/KX..^||~޽cbrt,ltGK[Y:g>m7t _NַVfz5_~\W7UwCt}~~3Xo}[_-wn{~g O@.Z?3c??;H6cѻ_uo#cʘ;oO}owOf?bsgz:ħN=@~O= ܕu{qW{yܹs^vV[DkW״efm\n Eo-W{pԠ\D$NO|ѿ'n#K5ޠ3T;B >d>Z*%׼u*"&-h<:a[nJ8xp]R)s8H2H}]k_D*oVj0vwR>^3:}^WRLw7===6^~k_w[l]+++##ӴlDu],-.=o}=oxCqZM~Ma XS"3kO[}fzԁC{_owcvx瀕d3iM dbbm`._wpכ}˗3cԻJ%._QmT:7啯 J@~;ɓO՛|!wo2~3^[ŕ]w o/]]X>{JȭCؖKx?yjS\\X?Fcn~aO=u 4+?5i$/|?嵅? ڵ˗o.'|Gg?УoNG>O?/y;{B@ȏ}t‰?Kk]~W}~W}ݯ73滿w׿oX]xRrq]w{^k_{БJdHadwqWpup?v[r[z߿w}_eo֯{k^=׿}~7ˆ;W }'O˿d{ww K|?Wá@kq Ʌ?]{wgN~~~O}IO~{ni!akOGwx@]OsI2H}"6D.}v{= 7fX,vb011JqUn}}P(֪αcǢS~Y]ɑ+F@HlGDNMO1c:Oo:0ւ2z!Qm4v$ͱcGyш|NMMAGGh6Lnza[.Ɍ.JlE=EU2F>Lqɤ66O盄W$2Ҩq>%PȧtJ Ocrrڗ-K4/0lTw{f3333T'Ggr4k׮Rvݷ<ˣ%$pg,-.7;;;6>^P.0R9J;::266"WfffvŀORGK/ x+G/]#Uw|ͻgi_h;۷)8z`#QJ|`lq=_W 9>>tXXr/KdݪVk O~LGU6N痮^z:|WW y{O}S=cO>qaYZZo~ĉ< Їx__S?g~??zWJ>y~C c_Uj7'~~x~}{w~~w'x_ٟٟگ%F`o|?G`{}) 'gtk{߲po{3ooo{;tqkG-z鐏kQZXv˲7KEwQ_x*7NNf -&t1V5QxNꓟZC HASV# Dt6795N^RYX)C<轫i~)XdCJ2Zr*Cp*;a9cccfn+Ts{cWj&V7^ody3I{14$6jtZHe2ӻf+a_K֖kXR*rCz&/FvSE:(Ξ;)3n2hώt3Ȏds{9|&'h H"e&G|s?J+f@^:tgfϢl0Mu1f߿o?ui$M+˥)x@`e١>ku} 0>2 FH6E* @!@RrM̤0T cKf8bHMssWip ȓl2nˮi a:BbP 3@l Z,ΥgQ}%1" h͊sIaPŝ62{, 4Pu4lȧhJBxCF% :L %sA\}O/ҋ htr\-6q4EU76:-a]E"e[֮] - ѓ>Cȧ2j}jjFVoV{I-DӀJgJ$)H_BۆnpGDˆK:.jHhQ^LD%~:ZNGe!D.Swa.&ۭ|%S]l(j]ѐ/,"2:ŘƗ._z ={<5kqPPFFi GIAq),ǒEb8rr (1 azA`ePQgUV}Q/_(|LQaId<1ՕU ۑOb{"O0;kH#Ƈ( gmu 9CH2)L" FiēIeP9xi2g` doḸ)Hnq3NHd`Hz}jzM"*`;^↔L -6Ao2jѴ{ eHLf7X פ͈v9o|^qȪ*˖ڡR=Y`b&@0ns"!S uC۵:µAbx2e9y@î| 0 v#aLu0pc9% hn$ӛc?QF3vv ͅp㱗X{p>ͽM#3WyfgMW :FkC5 x]A\[[zNGLvU,.@7V cb: sS3ÚR'QNK4QC}C8^9-I] 9FTBi5eB_b"iZ^r:*CS(M'}4DRl2^&)%JjK/Ǟ]r5^iTEۍv.-f1&'V_ k TΥaMX$,@/JLKO_ndc  L IGM%;ˁё:ĢxM7$l}=sq墨܈`&< g  2yAiuU"DÕb4:lYVW٩RWK Bxz"4B (BTŋf>_YY,:ʤs*Ёv0:6ObJ*K˥^8R,o X7>/[hg]rQ[0E g?x =dP\u7YAVfk}1"c?3D`ZæF[=%M^fFl-ǕD4^i:9Z]K0Շ2aYb$Y]CpaH2D=c=MS'-K@D1Nt3 N33p%Ay3yHC]wHElO0k8S2,ɊtNg1C?A&m0__j>} w: i"_T`+tHp> .qaI,,,>(K/H+ȷlcB\erV#k\p;`i`5 eRN 4l GH"LTaX=LaF\0ftHC3f*Y[ZCb9"Pi6/]HK$YV=,"ֲ3 4ݨnd p)H;ar?10'ӠڭL *ZXeM1JJB㴦: c?l2g8ц "ډ'dP_ o*vGZn#[]ڡyA!i5GB:~zWOj$EHCGB\?C_qQg|\/#J 5 )덴g>stʮWT]?- x/q@ֻ\FϜ?+ j76r2+lHWtWֈ,H<{wLtȡ H,j":C=$Gy:3nPk!f PQ_mcef3rnm< /mT b^_:O]`ky(9+t)+c>_xR.+#|JVJ9n ʑb+GʹR}}Yn2*DvE}Z8EeE/zÇnZbԂMLON,Dd 1t,(+-v%k+n3٭hrR֨8o :oJSk^]*JIkщ LIˋ+i~`m:9ZF^_[LPVL^o41+FFE4{ u2[(lwnP[yƳźLL}eGx|np`,tLьqC "f*|`H-gK9 y:$,6rSE5"ȝst0>SVdQMjULT^rjdB"X 8YiN%$`433VXD7iɚ}2ׄRάϜ/6&7")jP,"ozX-S\?㶾U\."6[fC v!/]BN 680tM1&b嗕4Hr{գ~-Ң Q[O61`Fj >)IGf'v&y0&f3#~qm_[%Vƴd^bd HH"MgBCvt2"Q.@l(x$f@%P:ZDN.yNAFEqMhOY;3er)AA$hgNX3gks[^Zg6# [\\w; ` Mfqcl˽;Qdw}-yg 10%X2LZ|YJ g⵲^x-Hf-BdU~84l_B,lӧOs7ӆzIp·XtAZB[n^{ǹQdӨ pnfǟݛ<1cǏጜ*H)lT]Y(Y8L&-OmcV 0,t))qd60l  Ä7tc\-B0K.>*F<#z+}.*Tشn\( 5RMwݤf<{A2lQ@oȩk 3(kIˀF`0<@aߪr` n }& ϼKgvQ\hSdfZ]b[s8WU.|c$}J U^g֗ Jl>#l~ )EtpD?-pzw3`>.!x-._yx˭jߎ(JYڂ+bO8>1qmn4޳[颏>(5m*1>~&QԶ ]bC,@Ccfvp#c2TzN,d|n D޳g5sS2mZljmC"JDQlqO=.OdP[pMXʼnBŸh]*ffͰ]U |9ga3vW%G)hM֚aϬ[•=CA!|?‘(͗1Q0S(!h8K v*E(Vk]r',֣՝|qG=&M8b6/PS[.JpLZ)i-PdH'#U&Qo:A:]ڒ9w^P^ >ҽ,.vF,bB8:] ւYؖ|,Hd^5q4[*XZWh2_($^h-`w\.F"Gz;sWbfT!N\hOWr:je*T'z( g*gUaz?!T1R޽|i:cG$"΅>\9 T@ 4G!n:Kc9aN&^~zhUQA*/gM=& =-gӑ,Hg%йJX ])Q @[E3=eC)R]iZZ*dz%6yJ/(\ idXwzH!+_EY $Sv|?_o\T8D<)>,! :w"TiX"'B]Q̧?Jf; l}ҁ0ybWmxU#ܟ]j!31B BqpB&zB&(J{ [B<4Kv5lzS'$5m$$^<Rphv^@|%УbIB>¨owj324/֬ (ltWy xCۣMzh ~GrQ$6ɭ+LA<^ITy,@@Wc0GXhGp@.ja&YKsgb}B XD'4>ʐ2Qf>%C"-!ƑfO],cDR7e*HUjX1G{X,:b?DX-ʫ-*XD"A=FȒ)ڶVfkZiu1Ѡt 5"2 AN5CIREBJmPOW#i{8UM^1aLVrڔ]oҞ'=n]lKAU^T] -==/o<%uAUp^?EzQ ⢧ȰonT"%4x&S߂F ラdfD ӧ@;hSyM_"vJDMab^%]g]XSGRݞ((c*Cl(! o0LG vVku;$%SAFB zF0f|i`!5JĎA.) q+sؾ)ٕ!h .}{#FDS6oHB/)riembIye 1-f^䳥2wLCEZ+B \v?0V>e! i4|*AD<`: BY"KڊN$19Qv3Ӕ_ia^҈N#/9)0G˺l)*IjE  @ /;j)|E>I E50L 9}w,}yao3 ¡m]&ۀ5%9W 넅;<5$BG-QѴ-Ő:$BUl!YDNY|ի @&HET”DO9%eIpk*)%VSXOfCbQ!V0Gꁤ6L۬ ol .]߀VL}Ǚ3t.O29CM `6exHmG6SI!R+b‹P`?kӓ;2~r^hv){ EygU95vY=ji"uzåLR9J١+|8^"Z⦨@#U@yi1#e:}4; v@rT6 ,r&ڠGCB8" Sw=q$ { ځsv-ቂ $!^.(*ߡ0A|dx( /),V.?i[ήJG,2G,GL$\U@ ^LhOЈRdE[ek5=rEtn"$& esi른S#8Td&ydTx]+/Ph܈)n*@he~WiA״<[гG%hbYy&ѻEsM[H25 RrR! ګh-:9w8=jAIy\'AS`! )炒`<3NWC ,xeʫ.mŁL(6')GaPf>ӧ<%*almor9lJq5l֬ (iDښnP$ 3pGw%R^XY֫)#{CW,J8T/K Xd M0N],~#U@/ЦrxzxK\ҍiVD>ҌAzpR\2u3p;ʃҖ8: %D)5BqdCd0DCi*a$yd/8. vS'I2*=͖L<ëpKROi3~X&< X#i21qkC&pUu$t-~|y]pXlnI38+4_# cxgCBYbusM/sMR=S $/"s e`[b3},-mIm(lG8cS=z NxV$ZW-9zD7zJ;#9c_dUx^ögk5mWЁBY) C^'3Oooz( QlVS"t1XsBfoo/pIS0`$ǩ[yr.zsw17ۯ qUzĠۥ{w;iA4P{y= 0?S9b\C@wXo.Fa}M"92 Le`y;A5-c,+QV*pyRÃ(@v- &+ qD("Ѐ/*e03!-?0X olO&Кm \'zF!+/&zLk"+ZQ]uv.iI0N_+[R}yt 3!YAſ]h-,>3iG׍ϋ  .x?l\'=t= 1)#)t@;9XLj1VqEbs"F\> ޢp6>%|ﮄAyXьT?S6yۭ^qP% R\,rW IJgJ&v\p$X.r-3uU,V(Z9".J ֙H'oZR4N'VDfhʅPQ0MPeXJ+=dp/j&,/EAUO(;!\2KFC{oR@&rQɮVUtgɠT'M6$i6V%'%-mvL^C+5$C0r oQi6O}Ɨ9o)7b@lwԉT|OU>g"tZDr4[S +6)y ,IivuPEda2qek^ @ f⒑ }ccdd'Mxl7nfKQH^Swa)M?/ {` vxꮋ)*͐`<ה"{+n׺I#nkBEY5%=D2lQ΂ tDzCUqX J; C߅&D(‘:=HHfKQ7]N L49ĴLwL-c( c=g!$E*%2ό/x;T%~ Ea#sGdr!IGc)UNZ6[ p WI+d\ZbHl@mo2TCo1,0%Y:xZ]F cv/ʈR8Z0lw)fw5]_q`&LȢ6(n"E@Ɉs95NE.;BrEyġ'2:h#<. i~.a9ZRRjET)*8bkrmC7x^!4 |Ms_ǶX3E![\o3(jL:īロAqRMDF-m3ǹjf)C+@kx$(Nݟ|r^tUw Wa* MYE!~{5Ө&]V Ө77BxIc _0yVɓ2C/=W,yVW7"lMi+A97E)N_JE'HO"C4z*Rm, RHB +QDFJشb}!^V/jS$~ ߏrj~ 딾T>D<b^hA3KBC<:ӔnŒ v[d+lR^#c ȼH U7%y % 0FySCc`w Hi Ht&KN&| ,ZΤ(k%jINwk6l)p`/ $>6ۀrT'\_F!%ٲ:p׉D\e9h89,+LS˒$-3!|;c*i0 S//uΥ曗<1|H*f|8ySYÂ|֋68m#7?2 q#øȅlձ0۝<}jvnZ t}qƋfZg 5)T,KIsGp2 H ⣴=!lP@*AJȢP3Iu ً"C|G.STeNMCek &ű>/ Ykʢ1ykn8Wv"eȫX[bm/_(1_2.V>1S@1T}O, :w0#r1aMR9K7 Jft?sFBtv!0Au{HTB[KȠSXW+ndB(@Y(y?ąfjpīU̧Ÿa꺎8%rI6bzLN.K "NVR:TTްVC;&=NrPTTv.EpZ351jZMĬ jbqO8sgn>r.c/DX43Y5ΈG;mJyN?[2ע8P `a.-@ N ~_͓U@;AV8ڳ궺ZGG7Q_ڔ+ cf#rJhs-8zH6eKPe-`k$+N. a!W(QYCHV˪, ^67 MkhϹ@d-D\ \^(#K'18$d@VZo~Nm{4[*[EFވ}ťmO`|gDtxhz2)e"fvqtra0+iH{^z GRg넸Vh0ESm`b8" 1#kj m( ݅lnɅQK# d:c=6F9] =n9qF'%د,#R{ sI?/^!`b†H${-|WVO9焟>޹dAˌy#n!AtSWDgWu͡J5ہc` RyҶPXxmo1S*IDW1Ҥ>Hta8^ˁxफtnexSA.3+,gVVщz7(93>E|f*HDsxjkB֬{cg؏'b$QqT^#"15 -l_!&޲:# z[Ubw;.q'D_^O--[71^qv\g܄nRM.[]u>{(toBf)YT8YA*q96cv*Ey ]̀,΢Vi<;5빍 ErM1siDf̎RdCM&v̮]""^ݔ\6K.5)h<p{'@B.7jWV2!A3S䄢c±7PI{{wc`/gM;\=}]< ?#|SgE۞`%P3*&O@KmASಡcCIN]tB/|"7)YtE/[R( a4G"`x! c-#tֹkWYk3*K d&xqņ*z)⎕PTVMof^Ib$Ϝ9’j@B8ñ*9ɓ:n+Ee``qv/wQ)3gBJaY낕6bpRX(S™~!'yWw?h0$t b j.8DSZSC^܁"/E&8 =C_#KtޚHC;֜v2JԸ ӖR bZlquܾ0b<1k*a1 ۄ]JB^Bk5QdݸhV0cbL\V?k*4 dX࡜!īG}!((Cz*8H~daiHu\S\p "Pۧ*`6<*RPQHHd;3cSy[(Lgu vgҩEu *0;BttDjAYq J~)wa\B_5'XJLD1 N 9d–n[+aR9UV~^ aUfR\bN\0ٵ|+_QjXk}Н:sCI*! (Z(L͗B^t<6Bj'#1BP*Pl0N7`8"<:n6Bb܀!Ji/cF zo iJaw[t C (#[,+e#07LqL DP뚴js[TšmZxJv|@k&g"իx)z@R^qQw"8 eu{ӈ/k+8 A2h }CNBkʽ3GsrӜoyj_%UI>;xǂE ڪIYXIc(DӠ dcm[rtm2$Ḉzi9WʈQF%i(d lO7#"6anXHQ#c֟Heإ2461DHr17 ۩YB}<ޚccU'L o! `,3 1 ! í] 2`~&@B UK0Mx%H*⵴ fvèR &X#ŵV֔(aq G(p뭷;Є%@m")iP4-X*I$~f~ qNS^j'8yDE G_T.;0HJaf :uJv࡞:K46r8$\Lq"0ut6A^tUQ,Ն7- q8R/X kI #io^J.iuKbcZ,GWIYY"q: M3}`$Ag:x}:W6.Aכb~VS8$5-Beh48I'# 6fEuY0iń<; [3)ΧX#fd7 Ԋ]x C8Xt[3{qSOa$ùdODCœ\7) W(|jnGz,*~I gGpNx<ЅC[7׺Ŋ-L/ 尵l FG9M\: *#fѣG<߄h  e g;!kAQ/*nzWɭ8qtͯ 6#{ζ(uW(f/Dv8>dTN0oytYx*l ,ou9FFiGmQ u/lDTVuH1̗:n^\ԱT IL+}D{i<1z8GXO"sDoӦow`^>G,T1pDY]&ûr-3/b1xseܷyLq ձ GjaU!Y YbbtRKr,7[)XYp3lLGJ/ ?>̩2 Q[k$7b'༼(twWZٲx.ɕHrX0VLR )޳esw(5$^o*OKKX&LѥR3%E]ǥt_"BIT@s( @:tj Y{i?w1XP7~`WՁyjq:  ;REBF$#^p+-ӾM1)pPȠѵ}˰=\e\ee<-ϸb*zO58)L\rdW4^z t@ DZb|iWAtfqNO,:B;DV;9v:bw m g* ea㴨ڭ C( ;qڊ Sp;Hҹ Nٍ岢`aZY4,7Y9pPdBӓ3?6Eދqݨiq E 1SCj>8Zʻ!F5wGX@ʮ+RShR!!UɳODj^@:0b4KIgJUD3$J|r6V%ߓ!O@~륩;kL"eD%u >\$_ La<5璘z4R"p}QbHU$J M0Bc1 $1=[#AhE+ټ;NbI 4w=M)Li21SA (43(9؈5b0Ky ZJJz# 7Gh+ebLKJtΖ\fɊ&J.2A@Xkg$(tBA(4?g}WM#)IA  /oJܛf&^O1fy[ \5[1.Ta`@m˞{PYMΙh /QLrFut1p74gϞ6%e.7rPa2tS&UbA!KSJ'RM,} h&SntZȼ}}8/(JuUdz%\@8TPhŭA[zꄍ? QGD8Xuv#7iQJ^\g5q5K995MV\7+7|bFʸL00$:gPL*302^Tޏ=HaH&/[l?i]NPDD/)0x1'(Z1^@RG.&g/A57r u,@@gde)Ǥq_OkS=yĀ)f ݻ2:b3CL'La*v^qb$ 1軠g&rM#]ʑ (Aف, CO>^LGCG,"^\JA+bj<쥍BQY@MN )y TVWa,'7Es\&\AOS3T>fn|^;w^+(i  .2`%eDl0z+Z{ŇF ً*HF=]}:ޟma"-^|9L9[F;3ya'ei(:@Fx9?VF-h|6!툄FM/ăUX6Ssw1`"^X0xRd {2{XC faR*z!t._C$2ٌd賭V=_QJL6cH~~ʪI3ׄNܸ͂)Tx{\`U+6tnf` b6 `@vJ:uM}2HJxPSN~N n%mqxP|hc 嚊IӮp CCԱz(Ծ(F"AEE@dfԩ"F=PI35N'S>|hҜ{F9*ɠʄJ@<\!=iAѭ[QE=PU`Oo&&.5e-r H`bQ21[Ng62e@S|fpRb0Z?:tۤt^}d'-{=t$J;LyC-J}[=ǟ)U8S.UF1BsmY2 ~iU ﲕBo*S7_dB4x% )knR poIg, 8$vϦHR"(3HyTNrv^Py4koc޽aLx%:A0s`s3#J}׈E;1j !9DaؒRDM3`?mܰC{# ̓t,xv$p\&K+V,~y  aP!q7>m%p[]mOQc Ӧх%y*2R=jK0Q@ZaHq\edEt"rt2ܑxчPQ/ k,sV 6P݈vCQ)N+#"G.,9ׁKDt_;V+Ȕ0讒l^HGJP'mz|ٵ-X2. \4Ԡ6pЂcl̐ \Lz8_&X@ lI;ԓ='^[ 3%!?YQ;_M-ZϾ#tao9[6 ?hW]/ {إkX` 2EJẻ/f7 `yT j F O3a j jEo~!Q:h9,Hߞ赵&WѸH%H P{d2kZVꤹ%違y=0dDx;uRJTpBi`ɴ#LPn͋e(;6JݳgF(G?j&ƚ33XoObjV!T"!<>Ӱ#c9iFb5PqG$k-iu"DD`.ʋmg҆ s=6Zt~(N(׎D,TaxܴZ(Bסm2 f( 8e&$ b9r:L Jc-sȄl޾y(w.3f/7gza0+e1Eg;=uA yp\@P3 峮D)7`t $WbPyfQ#\~zm5;Fe|2QE l#*`jk0H(P.X+;N!VI-KٍTfw GfqyE8e0 ߮UPFV<Z :Nx6 J2Cm΍Ǒ'd@edKb,Ja@CDɄ70×L ?A&b:MGT-N_,s"M&ᬄY-ɔ9RiTDoDlDmFA~\4,:FFqE!vV9k|'BJ=k5+ӧaU;zt7OZ}#Z|_DߌRcj1K/0hV%T%/u.<ɚJ<=qh\#{}ݕC&z6v75!$ •Ƒ|`hc*Qi+u:z fCTBbE-*F&lȱ#K)h>SԎ>Q|߽1_W8jK;Vݾ''"ЈU&(/k\^BWmPjțXʖs\'NO ^ #hp 'z@_=CVPUuAgmۏrTP&"Nfz3쑳ϱPmI)*D@IΗi/3xK[,MuL+0Xԙd0 XW-9csŘ|p5[& [H/\PH'|PTGj2YAM4Ȭs:P,C3u'+.)v6aH%' tb`oʡ)#dz+f5YezAR&:!@]2\|YH-1_G>]v2:g?|cD`;_<|C.L@0O;O& j+[[os<hTENY ln2\d`.P;ܢqިh5Բ"#ccě-)eECADBUb;`ri)B+I?:A26'`{-F6X5FסHInȚM?v\zYFZ+QOjuL þa >VL%Oy ( -5CT@$>9[3M89>j5'2G%tV` ĝU\5DN+oadu& PtwʙR, vBkO&,A :y͙V&."r6!U:wUŴ%wm0r|"!RPPRK BCᲥ? /B!5->L+5;y21@!GV#Dgc=Yb-]Eݫ}2e0Ǎ%R XI;WaH`czXJJ- 9 )8-ŭ6}9)$ ~VFSyE>T%FJ)֖}"md=+֎tq6ѫOqv̗n|{!A[\^Ŋ=Y[v'}lpĴVyCIOWʒDB}3;k ?KuW+ J#v DA P#-<2QN=ߝIBGBQsNmL4QXOj+fDG1xg.*g/6܋G M1hPpGLt:::8$DΪE~V"T*p,gCn4dcg, . ?waP,=oĚ!^zNq0aaUKprz=ģB<$76+!"Rγ>υAZ#@seĨŐpCl-PcsD( 8ȥ)ݒQ$0 > ]i'+"DIU_76o2^^^IylT004K YVH&LAGQdDvi"lqH ]WR հE魾i=όtq 5E K FX]W`ꔥQJ„'b %3"^a*(oo-_<>ċJP4bGU&SudLXZ} ,.L:|˹n`%Pʻ]p.|!y,l`6M&f~Gv"% +N҄4L`Ű|=UDngʌݨ g9[p)"!kתL2$'Jv p"nabZqk>GAU8`Xd]X\Z2ӳy1<ȌH$P:=5ͦ;wd{QI3Eю"]6g8GĀ7L2aV˥-H)!.T0>0c%:Aj,'#7q23.I&z-548PJB8ʁaDoS›_| 0K~1#!\ӲaYD)G$>"õpnZJ7[Itq[pc?kWyc8EqUM.esHxCLcaF8&H HA`A!H'l18$Mz01P[d q*RG81*Sת*ݱ.Drbv5kLy魡ŋkoaW977/7ʩa%#R=e{`GOk!Ң₉?}ud[Laʲy:&Ȥ&KJfu!x(>p6YwlM\8֎H|jnYm7٫mӢj!ft+ً2XybϳQoJQoGy@[k6,(_ WzF)լSZQ&$e*9xP(MmBjA p?vN1Bz 3`TI"8m|jCA;VߕXҠor1P)[VmTԮiO焬O.!]s8daR0?xD̙Kaם7ZUa^cyQ׊C _t-={8@eo{Uɋt|BWrM x@&,UҼLOQX/K=*NyGoH#e6`Tqi$^91/JꚊ:INQyMT)B)Du/ igʓEX%%1FbGƹx/h^y !gQWpKw,Y,c򱎢33v)С#%P@֬->vcAB9:fFס,롿A՘C8amwqON@!J!dNeZ YtFƀ| w] d 阓&$nrL;~ IQq #g&MQ%axhe4oGh:$EG*v2pF_~~rm ~mSLdt;Gx܁3shh4:VAӄ`գ  ƌcF7+Qװ90B](FXĚ>'#)8sm`8ɺ 0s_SC.]?NtV OJnj2Y#4ChfFr$g1&r' f@ՀLN@ӠULȍQ*4-h?ljkp[ßqtiojSPX>3W"I(0oNѥkp2(> cB@ 7: I[Qļ0$-`!GQ>у|זV(̑C5u*k7襨Z,sjBe~TjwJTq\55vԎMvT H+z=R|Q,}!.,I*!HFyؤ5F{.BZzE",fZ˜ӎ3 wy eቈ6P<3jk2*bKd $5$+, 8?odbN1"(8Zk u2_Ubw'ʑ(9\uH*ss_q|02Ti%M*Uc Zddҥl,;//gnke2' J`y@{'4i}aH>ֺ 6dt [M7!%#QI."T;J1qGxm "1E&٦A'HS+FJD 7R q?ώQ?ֽ|?2(P u~i37`n BdXBR-`DtQG-0{V50KTQTFUz0eu\ӡD(+Gh"0T–V{,! MΆ& pO:iKCը|iP]GBؾSSP"TbutJ1:YK y<{x;ԙJW;E6O#@c-Q4s)9N-9ܜJe)t$Ў-C%@>R %.땷L6yxB4ǎ! {qˤJ*rNO>}XS LvbfE0*!Xk B?|VK faS&eF03N53EFLbPOn`'1RR'\{RpZ =^L'qK~;-QnI5ډ½mf~< `;-}Tx{y(gޖ]>*Tt_tܕsχ}1{ w`3J=|ɝ_RC#3AE\X=&}?7jRxJ4Xs`&rf%'UALo ZA\v%u bjoMD$=eR,m6HN1Q|d[ mŲ]({UK!1Kk8|=t x2#-BEC".\>vugš,uLVݠ2EKh0M {3j2Jpyzr:Ģ1W*DЉKI'yPCQO)5dh g^.T`Y?e$20<[/Y,Y6gB҉L&O:]n*bfΜ=C-(jf9$8[V%1`*AE ;uYGyO>'eg6SmaʇG\=ҟ !K{?+.PKdIL':Q,O(GV~FUzL ]GjFmBm%ȈK=Y,!٩bR@/ʇ-ABC\.a(@ 6#zS]҂3d={PS=a1> 3B4YxaoOdd _''g&:c6n!)4ڙhI׬@kpYvx+kK[`J^4,Lpn2G;ˮ=q0@VT"7SgpjȌ?CpذҤEQg60e'yN|0л0/JSgaݏT.eŒXci=M:h]sUZ4ʱsL`>f6($nf1a'ducaPIIxmGj^?a) + IB|xGrv6=˯W838ದ(ǼlMM9(:MN* \`lHVq%,,vGaaMiOx7l5&{ ;J>qtIe!S*fU~3ΟQioC>xF3@[7| v Ql^Ar9%Mɣ{QYwXŐ`"N `6g`0mhIj?7u<:rQ"p]JCbvQ@E TOOf`R|Iu<ĮPTDFi ,QGYpL+HS<3zq2"fD0`؃XpN2xК@a@c;EPx :;Ov9'‰f5uPϳpTa(Ģ>*oIiS:RܼA뭾-X15kVI2-f|CTb cyҤd=tQ+ʣKɟ) b~TK=OX#ˊl{|@rs7`yX8araeTfr[ 4Tbk\obW#7P[aڞ:E1eܳg7";bF<8 BFEq`^w Y*˔H3ժAZrF'?&ڭ!$'ly5| !;GEæ?) }Pălt1~t ) Xt낭2CZ#D0\"We)UN"~X!b_>!G\94Xa] Ξ9&җ™l52Bt:v3'JIq tlq2\*gW|h1t xn7Ogπӊ.K"bۑcr׈R7ϭH y)7S4U(EIeSm% CZaOx,c?N# VBȚ=-=v [JkVP%ĘbSAv8 bDn&|SqؘE-p|Fd,PKz[7ԟ0~4މ eg\A1i#űqUlncybKT[fOC $¦T^P1ҕ:u0Z/\87ask I?$W/𞝝ah eIƐ ;׻A CĉߌWכ'Dy`͞>aĄcȏ4Mл£0tzԧ{M:E+!%xE^C] 3Kiu&<9 nTr h9;G49o>cХ$LEkQINkSbbvQIhAdB66 bDvLC_5l"$qZRyk T0wҮX5QG`EX%Ą9{V-_EYc$kNkq-׶}phC:.ூ_ x:3vB䂚=fpL&'-w "yEE^L ΏWI-pKaB1ԠyhxH DSTP-;ntEcf9f#cb1*븨O(Y(@w]KՒkYIJcV5GauDyr`R4bi@3Y 8ҾE P cٻ,<@zev 0Gz% p^D ^FXq bV-֎S"MH;qMxޞ}P\L{J R02c;T86Y[FBi<\wЀd~XtY}V8C/^&S3I*kF3B/1=r&)I4 :T DSh 䞧y׽ܥYG0 o?_,&Y24B*$W|>xe)Õ*q/D%e|^pTXuG F>|+$-L"eI1=MaHdd`d҆T _߷ojz=?C1YEj-ZU :*8qSvᾲ"(&UZw݈#jGQ7Dw˚܄E+;3o@ #wFXbJpm֣0L}v[{ɓ%rQ~HЇ6>$ p^h0؛M5)K(F * Ak.M;Κ G,DRY -_S6Xi9+6 l cm̀$wu@ QD\9gڃLRQNEL8Lexln;1O) 3qְ_Rj;LK=1Yr0s¨@Y܌MԤ£%u&URY1_" C{!fCp](ZxSm`A4!ōTx(3·~xb %+kGy[*bYb) (6v[omqp&2~BN^D⛶*gVB3"OZV%p?:o]Z)`apڕjFQ IZp>N=$v/g1{ڷk׮pN}Jpڝ%0uy*rC蒃fMI=.%32 /.^4U%ZBCS'T m|!4I1N(k[_N6#t[m7>3|i8)+ ? ־rȄw M69r%'T|D02MF31>1pu_`_}anJ# 8>4'LaٓɤD}Z(|ƒAU0 OV0!\[ ÄP2O-*ĎI߳ŋGV9);vf!=WA?=;٘2'^j6oS!M!ub Y6U(kkDHh]9[Ф)B"t}TnjحMROK-.\dy lgtp NGZ]%ɤKɤP.RΞ9,HH04}W~h]\b0Zxh(c<FO#P孢ET9SA 3`FV/h̶d˵%!‹Z22'"D\!Rحs`o?j:V'CB`fѡ'-Ͱ~7a%-8u@*E Hų`O c} ģFg>R0 ,Ӵ3SHQ~q\Ȕ[^G:׻r%?g8%PtM|͡2z EʕB{g>DYem8'~P~kh{[lT 3ҍYz RO{}bj ;)vP[NLb3 T Y/W N|BWt֏bR7{Nr ?Él0'Poq!VҶo#Kv9/_Th8-k.V;ONsc>CXVQp0]BP f4dfԇb`ZRUGwS.~Si{}FJStBw2_6pٴFeL\Ũ as ;OIGWj P}!|aaRu9+XZem+k^9QӾ{MP0[cEff[ǢeA \%t"e9OLeQ؉ ٕ'I m*13M"Q̈B "ꀯ 0nz%bn JlXLhv8=lL|P|ł0a(KdF]Ut>i_[nErJC.Pʕȵف\T̰YE9s]߃d^d0/&@"}3XE\"%}=28L#\#: ZDW$,չV**AHRtA M KYS{O6$R!C2j%:e6$ARr*21>f4.ܷ@ G#JA"7ZjIx'̧3 (x 0e"Cl: l= }ntYSa";t*(j fF`d,9D~22LUU6)Aa<'K=)W<֎ ҩdO(T48C*E8gÞ2c N={)ؘYKMC8>8Á r沋Sp>K˨1q++(PU&DwKo|ӛ0Hr55  PnޅBpŨe/ f% KS L to}RgC^a)gZa ߄;|lQĠ> I 'x E~f. SU%|iRAA 2zː(hzbʉ pm z! FԵ#ANPX``E)wyxFOv0ϏG\E.F;Îp,wqL;ٍ`DT0Ǜ:':rd eKNS srAH5WS(H@1>I!Ļ^H̀ uXqLPt"4b_ Άp%Z92؜PgW%P Е#hQ0~iI̅k[K:0)+]x@Ppeu ,INy U{Bn_Uy+C@ib|TgŎ _O\58 xEġ^h`"  N8,=ްbMXP ^Ei :PRNVl!Hh~rhl/O]~Ȭu~vq@\ŢʎЉbr؍P[<;nCc1X }:*ఃURڑS#MYZLPc=IJ̝FA,fO{tw kBJ|U5vQfΆcoQO-=::%QƲÀ'$Wpxޕ,~߰BhZtmjI`"~Û32j8fer+gxð$r(WGɪᎅ 1Zj Qmp)=zàkTg]qH~=JjrOb;u0;w )F"HN0]Fdcαܶ_[߻g?n(%"`nm a#c^:2$AΨCzi5dj\h;Zwv.-,I=^8HNiA\LBNf-k:X" |X}fJfb2 V 0<"sr)&@eֿ5#Fc O'"LDJ*RKSaVy)TJPm%&I'Y}AEyZjQɍ̐,g&;Ȫ'S&җwDWĊ",(("MelNs޻yIf GNw߽{zY(Fa]Dj%*DR4M"Q2 P%poиq%۵V#6g1㋵u6Ըr|q.P Z/w z؟dR6Hy:2A@:M>=p\(8Ma :Y3'sQnTZ_PS9B>\á$MˏP.4]$D%Z""Lnj@|M%-q?7檎v!qgdP^by ִC&q2@.+ KjAgO`2oU֯[ZTVUGYxA)v J2SC}6Hj)nH2_ Q8@n Ws37jfx7wzzM]=/F)A`F+0KU4!i 3Su4GeYѢ[Қ]>W|X̜^hPͱ"Q ۑqQprtQ( R0X2WxHlOmEqr`%UЉӚe:E:R>l9pw fj-<iP G ΪD| ֨0GYp[\B*  $/nҀc*GQtGL9"'vz%DXԥFSdSS\њvI#Dl8S4cƌtƫhd3+..t_ЩyZZ|,teJpI:`~G}4в[j6egI,42_n'jJ@Bp71TK D˹x{KkUxi{H DLgʕ*Job#dyw ďNL [ v-3(WQ8N"X:IܴdiBȑ0{9&s`p1 %dWl 9t>QԋoD`R#1K!E_j/଩Ղ#AP}$F$n^ Zכ2 6,߲yYDѬyL2=cZSOG>|%EDڞR,;ndH 5(hAm6HtLxū86QFX)qݵ8$d{nvPsx8 t7m&G=UDQ'&xEQ? )2 ȽɦfL8nɒc¡-[LЍ8nsJ 8}cHyŜ@ƱQxBo˰k!Q$ #aY9Ta#=c4FY9![{p]x݅+@+R>_3"N2J(4$/#G k"-N VYA"h@:I1^3;“˜dmC Em-=ɲ#d1+aCKdujvYŠk_cST%jdH*p[V+P)HDi&%0FAK]4i݁Qtϩs˴[o7n +"jm =J?_"J?#rDĉK}9"Έ )$V`4X)Kdzm̄]rv4pA&п EВQVNj9Ag+\xqfp-TOKN,X4fyȼIaSmH?6ńH]j{h=L%^PfQzb7B'O̐:xYhaAxDC׀!'Z{K e0D`c4ߎ u֛H7X)L^V6 ("G` FLx}~KGJ&jc^sN.D@!it8ga䓤XS}$VVL4wnK0  z4jN~TZ$Gԅ?0jlj#)e\Ȓ?ACߡR9qV46 q$ܴy#N%RN*ArWx,*^e@:$\K*JI  1N?Vb3@wJZg \"ZUXJەQQ\DһE q̪ǢDgSkMY'%͊z$x-*{a~67HOacӿ6l̊a$W:s],x F^cmC..R%]8RSvR`ϲӶa6rp 6N1 %'GJw^J)")bꤛ5m4xCAJ@2ע*P79ڋ51_0bࠢ@Ζ & vuB B rh׮]k{,-Fxܦ}䈫J jL^HӇ6UVJ P.Aqe5@ (5H'%%"%\ό@ڕ¦|gL  Vk? Þ wҐIhhRM|&6Oȧ R ,tB}ᐨasdVUˈoK L E?!X>ެ搠A%B1%VD;deLEIt0b򬢡X*B+ĜBaMLeN\TonI& 7G??W:F[kdOی3Cl O]ɋxx%dñ΁U X c=78p;M^2h=!KeiMy((M(dKe[M &Іب,jS:"8#oϩUc`+sS{%L_]d8UrW=S[|} O>$vZaї$ ӍePjH\JAan*)m-V:wVZe$aM~1\cE:+Q JkH[#$#%Sn ƎCO$v F18U۸KvN6/XgP,S4e-`x\I/I5 L4MKknlf_#vĴ:D)E [iE8l0*I73Z@+jBa+Dh jdAQ$pW졵N5EXH(%~j`dFz3u4˼AĭC4?PO{tev@ ԰e#' ͲH3Kc@DwRB E\^.VwhՀ<1;(h-yY! \B$;\ 95*iK&(]p5Lg & iXAq!Iu۶E@ D#v9Gnrt/6ϒ@(>|/tŤ( !e%"\rz-őiq*|HRIxdp¨;}z043#T1̲_NB3'MQ*2yEޕ 90 VR"$JA-&CBd:ũQJDn0yy=4PYBI-vː!ĀqMr_ 7b)q *V]-J3 2fFANʑitE;wt؂4+qk D$bLeAl`4&%|)}L 4$/ 7 ђiO! hL""dnF$< (zr!]}w'CS'lY\a(wElM54m̈́*.%g`0ZpPS--3iR"\J+/-EI7?ɰ7/X Sn2dBCh(Ex68_f]KuزQK.n* A&1 ) %eg[Ʀ\ eèQc#ҋA<9IT[lTfN[x[h`@%c<V@2/VQ-py %QJ݄QZIKY*Sz*N[;T/+:Qg},ZVVTsHMO9lc$-$O]")' K P% k!TDu}셌J ~Q"Ʉ9eck]1 S%[fk4}6|c7:Q+ۧ-l#Vgp'DZqwUIQPF s`Q Bd!@~MLӂ@) ]kK R"̉LAAcr Y/-J9jIR·۞{yfD26CN0"SRXw/x Llr=M/^Uj")[zr}ɡr*jd4UzkjkֱW9]| ī[L_eL6e-4xR9Z҆P\)E+2-D/!ڈ,u zM)V?rpX5Dd嗔75qMo !{,RIn|䈑(Z'AdkP c1^f`r$Jʫ0lvbo^+WxgoW=UPw~XXƧwm7kFʫ@dXP$:"Oo! 0EzE݁8DmOfQM]-&7RWofɆf/\ a(4BRc'[CQqm)Ere ~#46s[Z#RC^ƕ-aTŮ UV{D10u&e^40xP(E!;m"|~E&/e@l#oQgiPJ$ WIMh U-AC $QsEPMt g0"`3>ϙ:aa9q-W>@ RVz 1m{yA"$HI ̼2g"P5D <+\hHkt%9 jr>(((zE& r}k#wF Fʼ0mCZ\oE_c#ǎvE皿b *-uH6x|V`T)(UAƵe7VSg<):$J8S0 M\*!Rh*D(9,FFP[s$.a(2u@W)qAyEUQ)m@V(5mpb#F5'+X")~n߳l7QXg_X:XkuڄhM_iK i溜l)V-]RQ02^"5؄Zq^yU9$,J̬<kj#:'ޜ!IPeȂGsŠ4ŌJ}Lʈ2Z[ Kf5\Y/*hPBb;-`6Q$E<2!4uҌhumktXŜL*+R,;' @}A^Yu"'/7?oV&MqŸ扪c %U(f&euhM,F(ğV^$57PMcL*:Tg$ B:&t2-S̒S)$Q?glV=F561tEDsA2#"MGX)pl_ ?֨ǃDz {Lx`6hd)[]w޸r#Q".ki_3((j ՀďJ) l_IDATԯw% |x{SkW1oO -" îPU5Q$날[z?$ Yh|gXh*^>΋z(UXGQpkG/k#'f%Y^Ūa`7cREñsUe#(f;G/)(b;]4IfAÆ¢ 2=#,(0WE8BȬffeu"d&k=[jCU_]6 ołն'>}p0G$6cPB ;Z6ɴiSmkFISCH?#42"2vP= $f#"Ʈ>I /ŵ7m5!BA=ecOw4Km=ǁ;룫>$Fr+!Oh5j uCBCRku⢶*DF6I3$1 Ҵ CfDB^D:4u [),k_rm%KVr[1iITXopSԃaKɞ n""}߱B\D$+ԑ4CJ* +ku ۊ+ZX&j&[Efl&4.#bnU0Tc Y>[((Y$Yj=r6xqQ1ֵ%v4l FQƏoAx5PG>6F ʪ)kWW= lk'/T$CGU}Od?ǁu+ Y^٨ IŢ0-aH+QLĜd" dC.~ڤ%Qt C]`t'K{)HPCN4fP'd=^PH$+Gw[G[Hq&=ReW=jFxzt)iҠi0,y$d6"ò-eoE"l&f]AR+#Uy6r",tWsBzhØPq.Ҵ[ą[9z‚1K, <,[]ȤO{YzApfDQh|ۘc`k̒.%JKbpڭƒsv.aj6 JVpMTTB馦LB3+t4#F tOD2Texo: ut9=gHn\':C+%E(ygSD*5׾B@DM .B !%T`RI[VSbSaCOJ@M&YߞϰcMj:tuT~' JVAL877(" 80~)W"dzm(-=%]!gSsdYa`M⇢.cS;R(CD#-p^bUHLA]VD|?z5r? ­cw$/8qp$“a's:<3uj~ iD Q]Pi-`,-ngBX@`(E>N82Q*Ba&$SсR8f-]tk[Z)l(`Kc'WYO6d~$ʕ0$|M,RLn+>{l :LU157We$>7"2ʐ!g`va:1҈;K8 IkHR0 Xy& u+( !װ*maDh;N32~xмD+> ~nem ]<-3i)f/y o`S]udfC465S7Ƈ}#Bw#peI+Doni羉2RYϿ6.X*ۮg/N" 4uc}x2A1R=B<~pBAEe3d>df< FGAL⾟yP"E֮^.mLq}( FMݹo&[-߶:^K\B.!j_Ms`h gN)Gu[ :2%^ .V2em, =_$UcM- ꮍӦ&buIƔ0FY&s` 'wzZM]-CIJEc(9ښL,!t*P7}:`&u ll @=2^xr2K O1ʟ@rK8E6kqPT)GP( UEqi0ilqO<>I8"S*đk*=9NW b@5*>]x&d$^ %D ,0I"ѿR:!\RAТ5IR<ޜw]sn"b)=c7n:%x3P[$ժ| )%Ec GCᜥ$XYS ѷ۞1/Jqkk)@{Bg59V$f،i[V!s\bi+P 0R[G%nqURȚ~.yd9s@CqDT/Wb‽olZ %5|mܤ?r3+ W{FdN\ ,~y'][vF }7IAd.9^W (#< Z@`$ƄGh-Q^yUٲ9.Q6Pcs-W]eGϯIei8J$_@4cISKU%Tj+ V7T_td&QPIXr pjaZ Vp5 eF K\H<1qD0-ѣG (z:,&bͩ+JdvL>|<Nv6YpabZ\iEڢHQü #9Uծ)V) C]ٹKn"-wƌیm*B=m pepuVV95!|XFeA>D: 1+P~B[Aء$xб+M Y"+Vbcj7?gKX5e41Zb Wl3f,'{[bMf$by\IoSg N<%βHa,k^pܠ`F ~E)[(̋˞S(rg3\Ih,Z.,H^lxwbHƍkl(vC'^07n'A8b0t+Zc=<Ǻ{oTt!xp8rBQM='|e'|2g@VP00<%G/j>)A2ijm9֞g%fN~4눤1(p^|7lBj<-j+iˣ h .88 dq:7VT]p$6d (Sw~cƌFA)- ^*3TPoΏ?0 [뢣%Ek}i-_`  Υ* "}鲥"I=0sEM4rSNVO ІMTJvJN)J[IS maG2bF<,d.pb GJ'f̄hFűxXaaf?qbH$T̷H}BR~>m%5lkEa%EVJuM:F+ZyR3Z.I-,Җm< 2"O$".j%AtɮaQ3h~aTL)&6f^l,q4!mRTOlEM,KJ3Qbm_%SXee["t).n v+̇B:!B%Æp8$F . ,K_(~-JT3q,5ւPnN&>F2l{`se=f4#7o/+ q9Q|Kd H!eK)Eu=ۘW*;ÍIKdm3@$$@Q^otPtrQ# K6G8ĝ>l3q$͖Je|[Mc:ea*ثRMg棦zn|Ukd@˰ʳR甀QyE *XFB2|n+Vxk5a+4YVjz-=@'݌^.ŭ9Jq(?$"z$PQAiU 6OuL3:#LM/!ئU#ڟkQP {Ȫ1 QVqďM[6h8FD3ŕ4⑎dd3]`-SVҐ~l,6VO0dpU&LVg4KcF5}iLHכ,. p&*vT< D".IDd,v.9,/)cRS9KyR#ZBb1F=$ UdÓ,Cҝ`>+4oh)@Ѳ1Q\JKTx/;VSm-l$~Ϻ(Z Q9˙'ٖQpII1Hq(e_{(HZ"[]rtbC ]00#Q/"F Rx[J zWR.OB[,{TX1BuM%*܊*INum N =i ҙLΖ¬jQ4$#<2J 10>'#ݢVBҤ;O*'"Ձajc0I%l}?*|ɭ5&E Ȅ$M5'pGsM7eYks#q>4lDm DnC\D.sF^X׉!#*0 KFUJ<| C>d8$`#&|ɖh2ObRMO+=:86]03 [y `FS#ӇִpO@kyJb)ꧡ2C]=x ?2 /a`fk͜5K$="A|a+P>l>]EJ7!|0|M2!n*lcz>.QABNZk§4D#aH4q{$_!=ʁ~ _0rʊBIZJ$~AT#%Jc}#&h{GԈ//ES^! +TZ|uMmxHivӠ *5k[-iXr砺Ӥt>HIzߥ5pqJk0YA J}twPMdtBvH'i.ɼ-DLuwBunH\<댛nh1O\+gGO\15╂L3[p6{lxDix YCXj-RwcɅf&މyQpRhoXn=,*#9OCA4ې _"ƍ5&TGuP(Iru_㳈A2Q+Х3еש8+#eW\iHJdW!j@/9)k Ӗioa.rr);%BT !Hh\:RB6B;МGB@K:tJhN *%[cӔqvn't˘#Jj 0v}L(% fS@m9Šj[Il"ty\pp8fsP !bM$C3g2:}H=aЧ>kro}IC"Ǫ‰U20rd|0oaQS˄mmNb+*4}:XG1\)Sɶni֩`ǝ^)T@LuFΆd 0^8/"dlD.#8ff!olFppK&N4V|[<ӴR+L|ya Ne0Țx͡@Y\N `Y%0SߨԌiRҙY[=T2Y@uQ@%EiG֬1b6)x3+, +ͩHHe@V#׀uPA/ 3$8UM0cP<³'0^fRWROv /R )Ցm>xB5ExlllAӱsA<:;P¿4k aaѱYƍ8;:9.H2/x [J %zg+5 zѣ'FAS`$v>CJ<|!&+"YG,L((M@Hl ;Nd cJG@y+]{rw˖ʜ\!Qs:7],J ZQ Lr K(F/u&Rb^9rT}}%)#9<ّ җT^ľ8_KXK 1EHEIsC,:V\lmmVw_mki45#*S<+/k"8 *(:Uyhkwզ9ݹ@Aydbw`70xooM*5X˰kY "ZtZ$49D@lB}οPJA$6! -3O!6Ҕ2nf(I.Y^*qͻyRhhYX=ð%d5ӂSZ9SANXT)ф qX*B.OG9FDcWq9*Z)\Kx mr p2ǬtYhcE{ϐXl& #OHPul1c@P<6^xTILFB8vx)*>aZMkYAS0'FQ=Q&"YDA5䈉?xӘ*^%`M@SWm?Z&{(,OrTNn"H 1LӖ@r5(OaҰZ.eXcH2xiEKi&dͱ`:`ٜaD]ל6P29*)^OowδIoOhg;?.8J>SCY|p)&fvH>p2źjeՈQ#!E5bO'zxΒdkjxPglnJpC>Z#p/)ܫ|(5%PgmiR( !EȞLVCaf9c1l}@"O\cC3\0AF2#:5A$~i(áHU,l01*HSPR%_r?rkcK$"2*D |*hQ!^(bUjihͭɄ}&$mhМS-+GבvE#%yVh\#HRN:mK{nrQeByߢEL5g|himy6ij=qlˣsbIx|Knf8; zIaF&V8ЌBГ-,kl pfH}26KI2!}QbSCETL[ )$59hyZWMV\ 8 LatM ~)/:ZIꗪ%`Tf[NW3#V4xYԚ*Q}j&fXfΜO.[0RDB ;3qvvl`wAŌO* {0֣5[1yUSwZT:ݪ6*FHdjY6w[E`y|+ec[oau$$o&Q <=)VA [XTЛVh6G$*iTE P\TppJ5HeNN "ee`4BDOh^g30I@QDkpj'.9fl-&r!: Q%'qu~5°~7/J$q&h\z_DtRBe,KO qZ"d0 > Iv: Dl)zcGHA 8QPe"zd>diY@I4( Kl1"Ln @VMAD{Uzim- mK+ @o:L= ]2 o4;"I"=iy>; 2%?O={1po˟ufBSU gH4HZX2{n/ڹF׆ҥ E!*J?EL|}ݘ_I9hBںxbbP2~iXB|$f %v@dL5zfE$ˊBO :BشX1,x[ڏ&ƕ"/C]•0~Fu{,%&=Y#S{/cZ>2U墑_ P%Ṝ.DMU6v bB\5^"P74J/iKCäT90֬- ĉ'2cǎ ؒ2'HqLR:!^ap2AKdHly 3_~IsO0. 8M4OX8/c@3:rS[SEvxAIp+mh->(d-_y!/ Vo|Tmj%͹YgH%E :"AԔqJM2IARx,wQ6B2&(V=nLK*'1w% sEJQʈ^y>`йhfA2* R+37rNZ&Xf?+tHji'-Cg\j"Y@0}8w-o7Li*QB%ų6 k~ չ2 g$y/+I`&6uspP)YzI8ĻDTj6tŐ**[,ݲw F~quöG(DaZzsC}#@GPCwdV`W?JPBh0 ݨt"[ʬ?j%%8l]WN5,@{F);㈕E&$^$sq]p6RrY b0`jJǒ3ۅzSii]PUúDIK@2E(fG I=R oO9`)b!!U2/̟EL $Ȟ 6SNIM xx"04$*R4G=PWxa@G $Dk<&HwEQsP ,$xgK/GWP%qIAu^\:ʰ{5[ha936laB f/Y]CDX>Y s!gLb oa2YI[_J-$D WXNx*ѷX6Dʗl2<1K4ͧkq!odA(b9I+饵=I'3Pfߴy1]c8y3iNHSR,wY#҃BRHsIۈ_]UmHYX IIm>U$XjՕ&ŏHf(jXcӢ^G a9ڭ=$Բ3H=,v hv"NT^IZ/,O2te%*l y2lB)%Oɾ{ukzR09 r3oAԌbI3:bXV¼uˌ*t:?}r+ TRQZ vHunŏ]$'il;e{|е!9A د(|6PK4P/lGf*9UU5a{] V((FMEoO^pW^y-J_d)ԯ u&2ts.\epiq[l)z ?³OUwH^UdW_} ߒ,Z7n\?署q&U<8PQe7.];轢\ǽ!՗77%׮kwXʪrj 0_=t*&J|ӊk*/E(aRm@ s8Ư\rK4Z7^W_[Q{>0"&^/d :U۬[y6[+z \š7_Xz%[bIJWކoP A3:jj}+ Ig&2߰F6Oahp=иeㆶ&1^ױRJ7aE%d-zF/9&:\ !"^Vx^HtblhKMpspdP! X+ cމy1&haE#6- ڹ D1g<6[, tΚ"gUC h9ydO6W!*G ?FS577B~(s#(#nz6+Cshlr6a셉V:*HW XI|Wxk(ɥ,L.K?2%ȼ_N|gH>&G"_+IL-_'GO҅N2Rdwokdg]tއ+WyoƢEo}ɝ?SO>ceq}o2N=3ڛlQcf~ӟo^{M2G>?W{}w/~J?>sg.2? K.>`}+}g.i^{_]z>vit>s衇|,G?N8gzAo~D=[ϫgu=E{zW.cҤI!#0y}#L"qTd:?yW?gAWXӁ@B͸UCXEuhI6kVCXȨѣ++kygoag͚}h &X6^P:^0I-c|0قl)ߌXŒ_vҥLsd9") I/"EXS|j>AtIF`W8' ,m`Nc [0k٢QW%$poH|TWi<S &(Jf\CXȎyfɑdRN8Ax& <d-/4@ ѳm%_ښZ`c`18oޫ* G-[n]hF2Y/$M͍4HS\uqM.j>3cF7[V@hPA]'E*lEtKpt}^D(я/}E8i4Y9v[Xz32 Xpgo] ڨnp4鋭aޕ~x%B,o?HE%J6>)򭽗^{w%L" b?y빩 ] [,RUb92K}-Eem[Voڲr06ŠUyŪ_Xx"gDnhh͖Ǟ>wڬ)xk+s-~o?ݪmkuǍu5k#aٲnz>oX.7.g֭[zgN9NZן}i'~SN;nf=iv=;ȹ~IGtqY'\fBp1c=7)tixI1rWW}ǹy{2},kD'|LTF=g:s_#u 9w͏#~.>nl1c 9@P۪6{>Q| un衑fYg^~Ty{[o"x>OWRYdv[*Vԫۤ$()TlM&R{_D3Igs)( OZ[n fbɒSѳ?{rr#(sXiśadYQE|uϿn]vEG1Wǿ.!;gSw3C!PX.jҶk>|Aww{goM" LzB`iiZ8w x˳~8F9[z(yI74m%]F͢23J->2]4h)C;^ǟ|k2i Rh܋]h,jLÛп=eM㢘L#ng_6e` °.h J MxKp:ח8&Ms&Hc^[诐M?:8Eju큐BYNtJ/{@:zp0۴yu y\v]Ujl7%%;:jw]o/>) i'|f51uI2kƾ0(yMJOGg(_A;oӸΞuֹ7xӹ~ߑ?ȅG}SvXqxNDFkgE}ON?\M?=}'_rbOSO=_'xܘ7m5?'8Sk6FV{9#Pl\}5Jp+l1l-w[ao b*^ɢF'sp~">=zW_BYwoҲU eC̼2 :bhi-.#E:aF uZW`ڀ8瑬`J͊zbyvGzs}m3EcX^ll6ֆ ưtF[AA`n#7:m^ͨh6rӭu.(A4^ګ ۦ=`Yz6;ʊm9xʭ=oƋnWC̀XHz#s4G>oLߕniI<@A nf7.7 [h%G iϣR Zn:&wWkU2WX2eKi6g7!hxKУm-l~3 P &l/[m-E{[[u]PI(zp&x#Ijw Ka>OAB' ɗ;N].6Ўx.#9!\ }.#x664R.7N5 o)ax`v ;!ЉQ#fp@qeѦlϚGuhS3F~gڧ"m8J V\Flooڳ_ݐl #3ju#ʺϘO~R ~tlAӧx \u&xa7ZWQq~3$ Zjyc7wXhocvMG`l}LYY'7# @K/=w=92@٘٫ƬX'6`F 큺qưNvt[zdGlԊh4I/[sG1vQ>^@-]\\n؃vlvӝF F`İ{:v3x2~򝄷'L-avn6N:jGn7CpSAdOnm"nvmLi6nFm:$W`cI 2%/рev`tqH 0nܿ[ ؂}:oj~wFqKɬ6ޮv}ܨɟ[AKx6yɌ2~0[+pP z4J]қPA 8cQ{(n9kȘ`~K7+E8$xoC䨔ks1E4 07|rOkubef{ƖaVTb}4i2џ:;9YE.?xvl0dPɅd$.?$}]9JeV6b'@ŷtEI|}y/J7Ĺlוޖ΃`W(GT*|{{dږ͙0Eo:EXm˪lҾ6m$g%N}`mގWPN CF|TN1垳TGVKVEN%3nzBG8}6D0eTċPF۲ OoRen˰w$۵ejR=jdo2q H<l3XaHIEɳcy;v]ѡ@\I2;Ak d6Bom=d9p Eqe& o;v*nm|-$w<~z?%)JHzAzswL޵!Л$W&:7(y#ϠrG8AN\]ۈ4]8^u`$N}LP,V(`{ r'MVb@7q=D&;~wRd~J h}7ɃRf\'l=~`1Й˫ tG/=l##EGd1:t!\yN*m8zsOs(_oY) 3Mvfî>>~)NM{%! 7J@1) #vӪ6Vj/k_*ىnĠm*H8w{EM;C.cb A=mA|ӡW!1qT%uX_I*N 2ʤPxXJ4xpǦo^_ inU+@{{v٪a'7m'Hߋ, 2+IՒQB zw<޸!đcYI\Z$HW.jM(${MoꑶE:;"D3cm&FZOeqhvmxL E;e;ʶNu)A27.Qd ˄N?NL&;A $9 ]xP: t4>XAzNLZELHQh؂' 7vKHO RQ)G|NQD~y>xOm`1lǛ*1J.C ehiKjX_͆az]PwDfȋQ!l$7wnnjAi`n DͶ nH;v7{^oHj%sYx+e޶[ 0$[D9t%46};v2j'%m͸tEfFCxxÏ&I0Gsgw$zV™Vوm$ ҈\ܾ-Z 4g؜v><5Sq6ql$<69(S8ҲU YrA>oOcل&Nn/Y<瞟+w*XT;Si|~΃L'ƶ10حbIGz)p߻䒫x/͞} 1B<w`4#-։@x"# HՃy'?A̴XGZ8FB{XϷv} 64\qٳ7m1Y*"#)(pßO;z0fKfΎj7Zg^#2.]gGOjq3_7]Љ <H20H8}潚 tn$SFkO^?^'_YG젚h}m}챇֛PKURR E>Os/{vLw@utzߟ~)EEEmThmn9C8 {}Κ5kƌ9nIP3<4kÇM콱&l˗FZ[ۇ\*++n8&LI ÎËmٲǍijj5fKAAANr cc2}$[e)`IplٶB?h >8Eڢot\aòaJώ_ק2 q~TV·g) ]XP瞿jfWc&L(1̑E3"iaj(v?܉F^z-wq%YtbG!++;-,~elK<^7̽-V+Q93'-#b-i鑴PAQ( *qx;0H^%f〈3L>iM,Y>eJ}HI<3[^3BѴNl[𮺆{3I1ƶ~cff*npfv(=**Ɉd}3Mǁ:#jފ#SyoV@eϲL3=S~Gnذ |x=QF[l-E7+W~:Go~@Lm='R,b$1!s#FF K"%#G|gtA wpnu`oSPmnf[M>Y)ޑ^UrԈp/ov]wn\#():C{:0ٳgJJx CzTA_Ϋ}wr'{E D>xկsrr˟}3_v&|7tSaa-raFY֖l.f='tRg3?&wMPzAAkoᆿWMm\ӯii )K^:C:ڑN»ۥ^܌ںzD8wםsW|k ˗gZZPUTTwtD3srs***g55d^zΜ}~=0W+n**VW׆Ñ6Lu0/"~VV… fΜK/E|1L|7}2+_x9{or80O=~߉;9$PxedfvvZZ!Jo.xI'4":o9#$+7'Zd).&Z?XQQfdH8ˏ;W^y=''=2n_r 3PI ϐa#`ICcMm'p]w=E]X<j-'7`NU4+=K; @MrwldI~ `l L |Օ?7L2Y? .ѣ}g0(vC?6w/r,'N#%xשgAJ[>YX?p5<>hl.s O}ѣn8aGhO IQ_(++1"?WמV>oHLcb` Ƴʹ*9rTo\t?yJW8,.v{L;Çoi~|8t}QK;}bS&OU:"wæwq.AjW'NQ:eח_gO9#O99w0;#vt%|<#>C9cgGя}A{z#9#Θ5.0LvWwg0(-EdFj6 kR\33fwM[$$jvD|W6EG{O~ry魭h:rDy/l# |ZЁZoadrW^°aI'[VVˌhVRSRҋCppxP_Yg|FF/ xGYiSf#a0y8 ~`>js&02'7t!sX}$C8q6KFS I~_WcJm3+Gl8ī%V)O#<|Ee8ho.#9'i3#xrxÇk&5(Ӈ>tИ1E7't:xs >%0'yh8='Mt~^XT{mh.Jwn%b[GMy{{:1﫬\xT1ԩG9 ~~>rX(- 4J ۿ`v,3;SN>~st}'}gf͜G^AqQ(-k~PYx[o<  |_piܼbѢūWow}{9{'54T|o濹o!.qɓ'çN8q͚E/N:#;t5?3g9/\r=%د;M{ۛ}~1T;0MvM/8$Awv'RS[Kg>[oyݺummJJ0oQGay>|': Fx߂=&Wܝ|AN]xtӶWWWFee#[/o\t (Q*y `ܗNzE4GSnC Rt2FƆ]":fhX.#&+ `ᥥY@#>FH{_AAevv-8`͛?ge 1W;en]ky1n5'FBp 8VSq23[[_ywG?ZQQ6sfvfJ/?c:eö|eAZi*Xqq+ kY| 9`{/"e]9~aÆxĈH$f{%qy_9N:!ˆv /+obQǖ,l+m WNNa3b>.9233a]Jrq~wcl.?q|ɓ>+*5׬Z&+'|Kw5{s5'gA'DWVD23Qx4#q,BwH F56A5 aNe̵ .VÐ$<0#B ApUe5>|0Fwh; X2q;fNIه>Rȵ"9 TkP',W*? >] b DI|;s ~{a8ݼ|˖r!o\Qկofxw"Qp}:/W_}Յ~ cedf| / d#uVųF6 +Cʕ+sss`kF,g}P99s>hNUӾ #8:>ȡۨ:b8kT0YYׯOiNMIO>Ғ3f@n~p_wnرyy}܇>(jKKJ57a$_c?3`cw&b8tpE'7AD7JT[gpi˜_>x1#=,?蠃kkj5Ǎ~WSv78%;khL'qc OՆ~q-2V򤄀@(3@65m'? 9>O) iN$.q XuMÑ8LXck.93Acv9{***i Q &l k6w[}S?~Y3Y"(d% >X ,Nl5DE]{f/r2'ߒ9+klxF^TT[o~_O#r.< ~ƍ7 D e/|{,%k}U01C׎@[ipc]=;h|E68+lqce铝9+]KϼP=oXqs,֑YgDo^FGu55+q,[.2`XKiMo"+(,\FM$z!mIpE!iʴL]@?F`VZ> mڴGuyv^fg}={ 壣3NF6v5׹fЌ_X8˯qӺ+iӧ|{߭~trtT#Nc@v[WC ۫m0F)ɑ>ى}`^&P6Hob4׿Aw}~GT0'H^ūzTV- 7 Yk~٢¬뮻6-xWgAOW쌂 l알hc7,[ v nS}s_EtFoxfdg7 hϘB:$*v Q*u#F/}ޏ7 LJq;m۷+ʕƵد@œkjdۻM^ ogr('G¹ F}{sWV+_9'_񸌌Ǎ,)b939HfN:^B q6T4ь};]?e#a~ FȀZL Ovvqc 2 ѬP~Q$JN'lvԘ«P-E[oӇ;9sgYNTfܫ_}'m~Kmhl|! |6KI&Z9 MT]:7hJDtf\ӟ ?ȣO$mniwjt;RGt衇VUUW^}FcƌaK@̨fq?̑Eg_r j>5Â,^WRX4~yɢ|a{,{sA&eZ ʊ[o~s;l\\3f裏S \#qC¶+f<ݡ)AwQJ&5Xv$9iQ&5jٰw LO9v[x[QFc„vEācm ]:5bOhH;yQanG<=Ilcd!)F>8/xKH:a~:Z rISN#)*`MCɞ1rxhi1 4)v7U"AHz$J$ƪƋ_]}> >g~^Zo.Z|ӆ ľTUמ?͐Fzu-9{}O7pmvǼu3g7nɪo 8d~̀aFz_^wo=H fæILnR2XZw{QQqvUu>s;`?lK|6OR $KuVc^pRM7 >k'Q߸n+yffŜ,ar!אt6N.aԈJuxS>6 5b?z#OIҦf ( JBQam<]:C4_1wԉw@x{mFF 'zQUXWߊ,bs>ӿs~A8\__a͚wȺ4|R*K@W!{D+[A0b>Hk< {ܝ Ea;L`APjW?+-B~l4:3 yoXK/9rDG}TɈæI#h'VvN>?%OKk'0e t/'{sm_z-S:;(T`:-.o5?Ȕ7ys&TyK_?) ׬-ȀaaNbΛv^ză>(;k @=³HiBsVᇟ/Gbţ&RbHG>GдRP嬳|g7nlo*2ഴ۸ddY!@ϏVTz<TޘUQ:zngm$,mW?_r׿Einܸ\tEj?Ip\r=ܴPU-,$dS{W/Z ۑGUȡ/] 7f02+ڋP$G;DώWveWكM^o5aLQ<pa ?ϟ1jdΨyc F_1lB^ɯ8rT{{w=^sv6kRܼ<9w˰no#lMa=nrCo_YƜx!aaadm($=ųW\4"(#իWy䑯ͷHcNQ5^,݄MTlT@ cO"bx#LM/ O\ܷ[n_=xX>Re|ݧ?kFf׿L(Ϥ^18AY TPn? :};fҔ}Lk<?t qNę>d0'5KA'FVt8- qL)Ωڒ~X\0Y]C)^o!9-3|2u2`}R}njC}=.N&jn4n;9e+xe꫙:2m~vny::Юj 54n/<ףF`.)[Q~ߺ[׮槟<휾g5@!`G .)~s08 5KOQ/*iTEEh*;l; nݺitCv,[6_n8S[ۼwm\rDIч:BLQ<jjK6=_6qŒXL;:ql񆬝9_~=w#hv^7LI6aÊ~9;c/*1& w6Ū:7pQt̨pr3j/ҞvŀcxAأO6`RB[?wqYҮ,Z Zڗm(8cҤItJmyd.2G @Ž M}fQ\…{=ٙњv{^i=Z gk7jkomYC쎒6zrt {lct1qnNqd[vih!N =&cV|/_zɕo|)l@ `$nҧdg;Y9SK(tu'x= Cv?O׀|N]7"wI+#V0@x{)>O_ZZ*kãaE xG%[R{9sx^__Ρ>YHNtgY>0apiłM > SLZw{q("xDhnlJ g4p`0M3efdH{cH+2~Dlmys?mTSwR疛>qئƖӦ ;~gVfdú5{J4ʅ40]ۡ\vڝp(ͼs*$ʖP8źּ쬓a=? DS{t颷#TA ߋM!7AUѢ܂#^Xs0{)m<|D{_'8 IpMaQNUU SmoL&0k>.75o2_[7Zcƍ룑(4ʟzOT}5Pi𻁈o$!S1~֦։F~a83u,P4wA`= ݍmݴw]LJ -YY*I:wV 7!VV1s>Dv 􊐨ʛ'q)ڲeˤ)eW:/ ߂S‘٦a6$V vbp9(2j(]AIe>؉riW* ,wC Gi,^NO?=g} jZA1TPr >2NRM!pڤЯ['mdȽ7z\[[if|?2E\HMrܺ JB0to_~ .$1!˞gWܩZ ~+/<gr2,ԞyՕ&ڞ҃}ЌuC-5@m~((x#swM^L8p=lEɤǾYWT"^w~rip_~$%"-#I{ɧɰ;`nEt"Q$.ǯq\ۃE{z1+onNC! n6$G0 26SuR{Vezw},v'RMMEEQGMX[ 8CZkz7+e+`C[iND cJUUU/5Q#gOſᄏ|ҤN<oBa/Pv瞛we?6e^F.I?7T~qB%M_E,<82p "8ӟ^˖{Iy؁H ׳Ylc}ڏUEz"#1W\C8#? RWć,Pŋ_;Zښ['LCUuuW_ya^f@n?> q&"n65kW^{~s`xsp)?]ΪphDj͛_{cˎ9CPQ~1kCoCfVhCg6fg%DK##m}wآPoxBU UJv['d;ٳ2e;kVee rtj<+B)ƭmR0k&餓O~746Ů:Hn65կYD+|{t4Gچ[F׆<|T72eL1go~vaY٨^濜>r͙hm?^_i޷v@'xT Y7tQGsϽl6AN>';!]Nj GcRH|Cb2QI2ta5i^*"s`|ڟ6~S¸ @ɧկ~-Ѓqɒ7Y"{*rl7fu=wB&!̙] g\s5pRZ'ny؊N9}{..~aRͧiD"UUSggys//0dVV6ziiٗ_~YQ;sjC_w.v)Mpmq`)1|[}+3%W Nd9KsˏR.iA{F>i6K0]BRr ùp~QYr TR8H=/>x &N)Dn{&W3̘1>eq]Tj"ܧ7\5bDřVO:9m 3HH;+ 6K.0 8Jc ]oC&R|Nsc~̐1x^}OJJrsÔ!|b\u] ~rM`Sn]wog{1ʓ?+*V*cc2S8=O=jj6n~eAAܿW^iei9t}M%^1N depZ9X5V R=~¢p~AzN~˯>g3[e̘m:EQqef_x?IF x^s3<|8W4xsW&OS5(` Pwƫw5{/WfϘ@}v@2l=#O>~IiT՛\0SC\EcZv~:Ҕ9x׻/?yPaE!f0-;/pF#y~[§U]k7QN7)ȷ8#??P}4 ax!m&b~-by,?YidݘQfVz~~U\/mEV-4puOAe\v"z㇐#fϞ4~7u--؎uCwMU2h섲܂tO8<ÓΈ_uux;"'N=y /J` $l!@= DCF6*AR?;l, <,'R8,;$/,}ssӋK2M,=&N.cIfb 0FYc9ٵSDW-*ug_s ge TVd[;w9pxn Y8= Q鐨_zHV7 R(wA=v[cc9JG}.Ԁ5$cN[a񚚛aA)Xѱ<]ĥ|7/cM( N9spa upEI?EI;PC|G|gک |uOm؊:; |pA{Y#P .3XU%} Ri8}( QrYԔľRVeKÙgtm`@I`P i:1ۺ+V5u޻>eգ08Y >/Ra[?眯7BN()EEK$S8{߻#HXTDR=Ac2[R_yWOG;A m<6 S>O {N!c2o}K{ oj=HN+>XoT=_PC2E^OKkDWl:vU zD8g~r޷gW e8/x땗^ziɒ%;;ygP߃\ڑapG's#rfIŁ^}cQG9baQlql~%Чk$Yo[y'U_xy ]‡N )`lkf^#]Mn{IH{ŗOP<[׾& pwGK[YgUW׀ v/fQPTAvK<@=~l+nJRc$25}F=_5{'W0FإЍTF}:ćgovYGz〃9 }3ǹӟx¡o"EK.}9zc8 x8(m놠;؛un| k$ʈ%@+s8m07JL>i{<̖epK?$Q t4)$g.~q}N)qSW$ܭRBؖG܂pR7vfޘ[+ZP(=';"ZK&z4ڷ+JaaQS{y8a zRnѷv1Wv4,e~yO 鏽k&LH_ QK<p#~衧t*C{% Bis$ XŲ#Б==夣W\GxDzΎ{W;oK>C[ ;;4|W%mKxçJӞES\qv3ա Q6c8o;)tezH:jLD=  >P6Gh+ QxUvIFqȒ࿞& x=:yû;7"g'/ : Ԡgm/# e8C:qN[i?eXI rKsR!CA/cn`]hvne ^֏j[c#ESXZ{ ar ?M3V&+f>-PuT.A>. J40@]qj.rPro |}N1qQ;. =o: #q7ݲ_u4=^@LIu*}K`֭ɶ, 75guyk#|]/IJaXfV&ȩʢ%Gz,soq! şq nD3Y3y\Sp(!+#}@ҍ*yEA`oÌ6N7ZÉ עw98ھ׷'K2ꑎy 7k D h9'Nک6c/`<0v^<DBj|S<2^,%,е!U+} 2:g<22XU!t[iL껨_wZRVbP=r$ԩn!iD~ڮ z{qOi+q*Cӎ[v:zPl:ŋS<Z6s@A )6S`A=~vdw"vމث[[[g_C9ɤ:e$>xѪ#-c׹]gTC#vDyP)=Q!<E}Ko @LH0$%sÃֲ]\`Yo;0ǏubuqvF %S1$J3ꇈEPjU6v.B~R.%ۥ>졖C }Clrr~,)AQTlmm#8/} ~7AP]34/7 \zL5Xo9 EʊF!YYY1ʣJډ?u;MzxCHWPg.N3L(ѨQeR">G)RXL=٥ M6cvY; S l ` \kF oRNv (TnVN8L+ ^?m.b3  ĘqzC66QB%H@ )*33dEQ'"[-%\p7!k릛n|Ww*&vvz@|:gO}'~=K£6JowmͭmlpZmW<~L:5{~;s}p1swQi/p<].޹ 8[Zk[((jrvp(͡VTsR<'I ߏ.j=_RkH0)۲!{/Spg6@Gr[ VgPXVfAvVn+Ɓ9998Jpby />x|I$zIS*e`zjWp{~[K0N 6*}vֲl|{HE=`UsUbmw9: J y…AJL.II]}C!?%xb\Tgc`B{=4ɂ>)H"܍+>xNrث]D㷳l#m^Ř@صǰ@=^*_v$PE@їJG&)\wn؝b[|_/؋/>Qln4Z! ҧbCw}G Uw;́_N}P];{mu;1`yo:9c_SlB }o?tMwuivWμ!O}{ di=CK@BHRT rAχ L߭~F 5|DL4j欉cƖ;l'M[o?^ue^x׿~'8yHxŒL=jm~YdEʺM6ok^l"-?vOF:Pvуm<-"N:%'k@q%IXC%K^K.[vE^W8hx7_x9S$ [ZVX]PP|r( *326 5 `+hcZ=2K/-/‹/oG߿,iw;3[>>ݙp '\ ]ͳOa?ؖˀʋ/VVU-^$++eVcJټyرQ=-Yϝkϟ_WHWxQQq{Gѣ_c r)( om/΢ ϴn'##heM|`dFV/7Q8{켼aJzgŋ/=Ǐ5/Z[wܱj՚# r!G+K&`y'}Yk?MnW8̈́ yee#D7lzמ{~ݤyY\# !QL}ġN۴x ˖-mC+ΏoX>Wf*}eTWWcGpT(͛\JwY8oޫ0={?};%}oc}2LQnw*/aں-xۈgco޲: ­3rM߇V^ =+[9nrFceKa[;7lll`֮]WWW X9ҏPϦf4Z5{Jz7N,'00=f!C F8V0S~@p.F3nos <'0u Cݥ!`K8 aCvR¨}`ކ$… Qam޴VrH6P&:#LZ\\\T\FGR0Z_y5k֮\:zhSgڵk+*10~^sϿSꛊW#_XY0vy]W\~>+VOIPDpHAy3kmذ`{'*5* ]BȎ׬&i6@;Q#2M{Off&_vg:qtvp$mm֭}?˛7{~߅%&O)+U6XKde: O:{_'\w:OC 2;77kefdҵp{{8u;~빓4T*F~hoxZ-&sG PҰ׭EDh3GVG{BB :z~G|,ڊzmm zZ~ijw 1>a^Zŏ/ɾsGNϯ.!ܪuTH$G}vSO`gwkz쁥Klظate̚5Ϸ?B {g}y~_~tȱ#.QU#5fe+Hk_FP{[oQLk3L䂯}"i%DfѢm5ڲw")2h䇻h܆8!tZ-m}`XTm4d6Ny_ =F!P)w [/? Zچ@uimmfjK >z‰n=TuA656RI]YU-\pڵM$d/Q2N;%Ol斂h{CM\v˒%KC55|\z3._⺫\0fh\؀IqDsHf1F67APT@:J+צMڌL"JHuŲ=,r^hA=OŬLT}%EŮ?wyO>l/ RTT@c͎đ-V  ӮxXu( pm~t!9Fu}4ԄI&^fJlmmܸqcsKssK 'k?Yy;p|{^1H-o\0ޝѐM/+rGNַ]J3e4)_ qh_rekKرcLO|߻a~ yEDѪUiGXUKE9C0{]dr6mΎuvva%n@wquu%%%HX7e񖣦|ҥ&4ޖrZ>ÿ]w6wy=#wuk+Nn1t gةI8{eQ:\$JchIWWg {iUUX ޚc-XۖMJNCTFD4w ƅkjjkc9H Ç9mvOBrpD=ۣ:PN꺂ܜrA<糟inj@(/ |Ω/vf3O\n:;'uks)&290-mٝQI Fy+**OҒk紷=FmuoyђMw;k${CE9DHz >{n th2~pss&Z@x[SOO1CvĄ ǴCԩSI1)ɦ=F)?={_@***wkjj:辑p쟑QXTWa `۲E á.6mFWG,B zMH-/̓b@jTqڵhiĉE]3gh΋(z؋/Ho[N>`u4& >l(y#lKp_~i}&;jO6.52;eӿHQD@ffdˈFr$*(-BfRy|@ߗ}kѢw0;cYY}DPz%Pψ#}A_.4lxmmʕsr8>:qDR}pӦ-e#GCh@ΛY/SFWjM77$]_Λ+] 1Ғ"E^G{gQ-.!he%p!JuخʔIFJ>'^_z32#z=]g7#R(qQ}hrHd4~=;#ΝDWҥF\#푥 imjr:CXdR0d;6(*?䨌- ?Mԥ{WFmؖ:b$&R|KPqm؉??_pssy=J+t#OHƶ c-h49Bz᠋H+V{X<&E"474`0[|+W.-90~| }oؿw^~S@z9֪Gx<%Xl @ u>Dfހq0"6m:z}!3%ɟ?I+$gށ8wH 1jhmn>X6i,!n<6&﷿d)7%"**%I@US4FaXr O,!쨹atXlГ$]Vϛ {lz*yu 9)4|<33X(!+z`-ރmt,Pϭs 7V s=O;"wVV664"%fs &ws.a8L~_2y2eʆ#goJƘ S,D!eWpPÜ[I7[l1T;>P*~V};sСoH$HQzsت%8y"x[*n @xӃFkSݓ=F Ŋ6jջӧO9tT|&|U@h$3#+'K^bAZAnd%EF0pVqx(J G`W:͸#%%# gn2YU&tEE Ϛ5_m! .9nQ ٳR#M$P 0ɁM:bL9g"&N7 Nk6L#fJ~: }! ۴^|]+}[ |q'5R Eqs>u@buK݉Vq D`A9&M %_RASvj-\Ꝼ ;;xp"{~^z CgpPW@GNr`: y礂_y=#1c::CIH6x *NQRRDnH07a9s ^}lKW3>vg{;#_[~cd Lhxc:vA^gr-Ѐ~bxGǩ(9eO>F J 9&gn+vI`; Č`Km*s1 1:vVN $="]XOJYsRە>٬.QuA}?ckuTmHKk;_5k5@4 B/QdA\.TϏu6_}?𤋮:u*(,:DR5_Z^o**ݭmR@ p;?zpZJzi&i]]yl7M6f ]sn:[_ .efak㢋>.$"+P0>[ CcXdVW3` ĬxR/;~rmۖj4Bٻw_g nEё~,ёCsz_3g@M -& q,>B;(kj{ѻDY PNN+©K6 `6H"K/?r~MCSsLnx?} =n (.(~6qǃoߒ}+ H" DdpWvBw{{;_yu"!~1+W*υ{/yxO>Uii\<"uxțP i:9yWmU|~j]".K/C@΁w@#.o/b]K#6  ;(_= +DL# ؄- Wg[#ҡvMeM QDѷ.:Nr2pQ + :$:oE9p{5r9gF&fd?R}Ć/w)$Oٰ+uʼ +{mTO?;ֻt;d Գ'O,wgwkOQPRUWZPR"HmNg]Ss2}y|W[_rbRlHDFu }mZ_TU٫RKK tZ_U.]G{{e7 9) LbT/G ó 2uZ&_kD r䉌 OMM(}5e MQ'x|jr=YyqsmVшR(# җ")j` V$nW\B%goIvH7:LVT>yb'j&|bR>#o ܼBսxTJl寺jR3jko[akYIPr X$b‹/HHͦ=D:r܊PW 99=\H3$QVwA^}&FB 6رc][sJp0fbD9ؗTjM^*nB`s#ڂo_(\xK.u!bT\0*r{6/0F^d !im?ໂAGkj'~r.|͚ow嗞rʩg}Μ9# |@±*o97 Eo2!Iedd@F+͟%Ćϡnv6nDS´4 =?#3,QL da'R5ml\ _]};~EKCìi~u~A i w٧SJ"a 5bУ' NE)NdtzmBdp?fUw,6|ɗ|н4垚Y}V@]Ԕ+.*-#vz][˵vpDws7L.aQG|"SO=ۨ]jlua`Pm0k.ݛk"" nƄWZ7Ꚏixgu&h J?s'VZE)bbb^&3\BA t7F0nXBD>yP#ħj1-QGK@GIOR{A= G s U4B?}tfOk肜s(3/^~ ܬ9AUO^}[o޲Wdeai(. Z%B;WHB!P!*V;IȖq>WXpZHr??L{#/8F~CsՅ^'}e6<"tCB|U\ ~e6[9 @iei5ݗ[Z޵ݗ C֋kW o ¶ 0xcjmn@Ǘf_~W?(Zϋoh"kks h< ѱH|JIM 4tcjꪠR?Qנ3bOEI됛 XZjZT}%e?R͛{^X#U*rX){D˗_{dē9%k*lP"Vb-(]g4Lv_rŕWGLɞaq؋KKX&FsMG`P6_nB IT[^ XrSȜW ='b|_KkMJ+p`]VO>ǟcޯjl]"Q4",k^pť]5ߦvo͐cӖ/Bh˗ч_vwPfg-  rz@t7 GKQĕ=@J/ܯQI##>+0h4А"z]74KГN:)-5dྂRo[M{?@LdN=䩁&e<ヌ)hس'A\c(u)[QP``K>D+[d@y42ȣ/cE\`=-˾kp}Ǡ9{p2g8RSS2%\{#}_v]PpzwoΞ8 tv']|G|q`.07ӄ]~]JY|zAoX/L _q?pv ]Huƭ}D3^f2#@zmLGtir4@(1(2 Nm]C\BO(sDTC&X+<72 LuueenOC xR3ed lU_""?x{msݵח[ *GQYNKJ{ߏrܢ,ܹkӒ%h"5Mm)G=hnO<@Mk~]g׿y8fRRU]ȿ5}㦍Yi(DGE_' r+۷mQMM5,յg0,%f͚ -_O!: 9jKC0ȠmX08u]v".vaك*?gϘ+x-Ho'R ::t=kR/~Kf̜N>5%yZv]dBd.^hyII z]y;䧧͝;B.,Ml_.'iozge EhxT+\ 46sT( ˜H#xD́QO^*ZZN+ҳ@ƈjOf!1)~ّ,ɧ`a£s=RPxSf CBD#4`۪*jZP{_tK_Eyܭ;hJu<r pBB +zknG9fo߳SOE :s9ݛ{^e{ַ ..VW__˺_:f(R:]srrb|Be|7cЏ·k?A(1|VIvpM,lcN?S^ }bpVUU!^d\z+.>4\"?Q<=`  aV?W/mD],]d͚2DGB8/ʁYfϘ>e+z ;h>OeԵ"z;RgW~EX =_ T=K!~(s{meuɁºٟMC }8]՗_Fא(^ҵțHDrn'4J$Mw]YSkj3Om1w~$eg%&$#ނ[6''zMVtMHg) =ү?mjjGX?T߄8)$eX2 ˎ>jꔩ0!$=usPtC|%22"1158GM3ٴ{n=HNXf#*#*==kɒ3f,Qy^EonܼuΜgύ4!G_ 'vPG>=*,a@E SR2#ٻ;kJW͚=hNl+_{eWwY^N1Y I``f^6Դup33zCX.~@FjK҉j6lkx{hlrR_\} >]aIuW6T˭omٵsl_`X3kB5S&U`=LJ&ا_DhGa? zZ}64N59$> pQ8)) ,6ojiIh^U3>|LB3{ @좋槟#·nܜE%KUTXoJ=;qj޹sZjwƆS7"26+ - jMwuMwODQTqx~Φ؄xԉfMtWEt`7p0R 6)}u̢wwA=؆AA݂`1&"vRA ƹ"89W> V:kQ5o'By_ CzW}Η_v \`өoxOЕ@,ܹE4p "=>KsUq}? t:N$qV?Pk[D"gEtu"q& -X/Xǂh>o_w $xuV.SPx74h?Ȁ(9!7ⳃ!kUU>NP7qRS..7m a 8|.&FݏqJ|t8%\`Zj{𻜿B1ɻ{KoU F׎ E /VCB0`R3&F XdC #H>(*BZT, '_tib:hQD z=X~ A ~}.J~n~ e諯>"ԡ%ԻxFQ'ҫIAZ("m`64Ab@L-`1iP! = :Pz:ȹ@)} k:"GXZZ{c F6_P8bՕWҷeB]BU$@b0Kvl[`{Uj|Um/G;9f C6$+H+!qTt D滴y[%9*G 1>pt[5uD T#Fg#Dȣzd0b*'xvoe4U3Pk_Wt}I!518wAlХ|"$Gc`c'SsvEBOpP3ԋ R(&3 MVL}kKJ(=f7$_Ğ@€0ˈgOpc2 @H95Jng1L U:}AH3haHh}II#D>1< c &nD[j!u( 7G+F#immEu%pȻajo|a 汣J.ʙ\dC!$PT!/<M( )юjQ=%oKU^'Kyo7%C!p!Ajpp'OdqO,"hL0EeWR @G.0C-PIN?y|>b&`ߧ0M|tDXTD jXB$fIem۷wH{}.(xFx;Ȕ@7R=~ G.(8psJxGTJG%HٮUȕ RXX#")GhtC@ :5pC! &H@_]i.򽹹Т "zelA7r\ID=hy4x!C!0)*D9QV0yD u^p}# =#p١(~}2-7`a"p `am $GP$!H;}# |}QQ>QT`Rj]’!Gu#4teq"E( ~~/0^~&1kC!0"x~f"#P&Ey\ȌinL-Aeh/@aq1I I?ldc03~eeނ .\BN!65::o ?F.1v{DM+k1 񂀟|"KM^`>"rMbq(fd |id)hXCC`r";{g,ryʰP{ee.F`0F|5wq^mA q5pχǡ6C!` MBKC (פPoaPVv0 CU/=.tsJF8Uo8t?!`pJ@0x+gBBf!no:p:dq8 !`0O", T"0#%RD>*"C!`0F.Z__CPב. W(VB鑳 C`"#|[&Wj b""b1 wUe ф PA$;b''tX !`0%4'x#PhBb;ZR,J(jЦ`ƌZ1 @?L#5M|ONhK.B ov o~#/t%Xђ5a0 @@Ht

AB) b)XC!Jd2r{P N$EO\Q n C!?11t($y%fIߕJ+x1R bG꒬C!$`C.qD!j tVm|6C!0 R88}I)c%%w>8棚DO*C!iR QGaG8H$nkmѲ C`! B!EQL.*Û?`0bRZ9'8Ev0;.=n|]6ZC!0~ AA|$pRPټ<Q`N3 G imm!0EGG >XmZBlECC!04F.ہ.FQQQ=ido?Ol C` @ $G$#jG*E:Ol @8p/7!`LN dbHeRDL-ɸ {"fjqda0=@ {8@G"!jp#n[<$7 `Ę!]!`NP"VPrz QE"D<r15v0 T Azj>FCޅ8]x+O#'}oJ6~C`  HGg1[+SM C㣶EC!8$0[-"J)<  ZNHB˜;`0&*f<Mp!$+1!c'&`LNs`#@Hdl!696kC!p <%P"_* 9Q&0 ɉW8(cb@ȷ&ҞO5C!8tE FRkc#A۬.%wbL:]!`L^hPvp+ W"@͜!`S$bd뒄('D)Ģs UWHXŔ C` _)q}N' =@$ !؏ (>Ca,^ YL"u%w{^n>GVydqۦj5pY.' }X&1NU RXgy<0z_{_x?/qq}w[blc6|l.ʮ2DDF"VdOKqO]K)ӌ0vaN`ߎ~sܝy9;+Ln2!k`M<HB!ss_mjjnnmn(,>P[W-+'ԻgDK1tnܸ-B;<*3..&%%٬&Q,22VTΙ;WeI_}Rļ~ 3W֖!8<O=TFB߮VכLpI%"JKdMhWPߍA__?`AΞ=!`VTC#N׉ ۛ]SSnݺںrߗ{^W 0oo ݵqFMH8t9PE F2,ԝddlZe |";{趚+Ց)jMtBb֒$'M1uނKS; @Rs utz<oRYzOLͮI]. J J++*tK$kZɼS4iqtt4R*Jet:b5um---RD$EkkKUU%#ʫ>| `_xO>yO>Y֭? æ`%MY؏$ksڱ7")UEeo.ѸuђH; mYP\Q_TSW9%."JJK˵Z-L{S*A"T%ڝ[^U} 6رkÆ-7o۹sO^^AqqYiiN| `+3FlLp>lu/;:Mܽc{^t\;į-ǸOJZZZf̘!t/{ܯ/w@q駟>g, 7mjh~m4d2_/?䣂Ͱgdd\p!1C<?TW>5!vCD믥eC_hHw+!FX0Q~"KH:5Q"3g\#𞘓O8z?yCo7665O=qgueESKUU;{Թ3n[kKpr~?%$Jsvu6sˮ5|b9bg0Xy6zdž ;w`֒C7QP0{w?,&$WȏXzĒGXQO?[ԴzN?'ۗTUYrEEE_ukN:-VoH cjj^k.]WC%FKj{GΟ7?<*هk#YCCpB஻n|7"bjIz>F#3#SIQiCkxtuO>ʕ+a3gys,WqvW|F)UH#O;l?SӦP%66vԩuuuN>g9ZxYdDD$klOK{׶U5n":, c@YmAQm;&(U`07p4@"W nwH%R1z<"47GN4f/#j4Gh֬ ]~4g3 <QI8ؓϟ¢ 5w}|YgBCqxD$V̝/OC_}ulA5c0B@L2VL$1}dd;g2rro&@קd"##;;>=甼n9r l6 INq[R\B80ijgϥIKK $NgiEen~An~ў܂}*k$ UbjG(A`Hmm]7 AvϚ16 =pxGbo- Fhl(CB!//H!/ SԨ~ ÐG/i6{"1&3f-Xjuk[7 H+++!˧O̹-%%)))wO?[o-]t…}^xO3=/**ϴ`em| (K*R@-=|! ]{Gt= ]4\ƵuKmiO̝TRMdCC5<_ %Ԭi=sz2͚Ԫ79?"/:<洕WA- UU'ponOIO8p$JTeMH t'(Xl)@.)$H _ GDQ>"{|5YS܃Um/A"cSҖ}\)e3JR_#ʻIzQ -R*Х>4, Y.A'&%Mj꣏>ǓgbddBT؛`# B<#JaA*ٴnmHklkiz'=bnZX>HVݽ{ #I"`0k4ꖦf,p#x cEhB yr 6+dcpj: E&]VnEjM&3Yf\N Pfz!<<,%%v/` xFk%> Fҕ~k0< 299ǐ)sW^LB$~?saMlkn.:P\u|qek7ޗHxrrzN@ LDxïA t*RKl&6<&&9u<(˦}ͷCi +@V]q[n%!>jhp#'߿CF#\ujŅ6x>RI[)@ϓ3 ErHLf]}}H$x svC!tq:*@|U~abRzIPS G et6wMf;>z^[b%RAcu[7`k]\tRHKK>%VC)t j!r|DJZ{tT*`N$ڪTjPڣOpnQ c2I:#"p[ j3fɧu9C`h7 5"(I"1DbǍ C`ϲX̨GbPρoKAW1?mC?<]-ȿbCj4`arʪ2)K`xWU329K ~{#6#ɷN^?fr.JQ>3zN;?׳kIDAT[bc &4[Lg~P{f1"0.ˑ]X-z}N؀b]Oe1^xpu46{RaJ8:4;xM#>O_}I_^7Z+PJ\(+lü@'99%DMBV{SBimmc>v/'T#0 .mf1+**ृEQ.DEwϾe7peIJLB:TVV̞5bdC!0i"#@(<[(Dķ骪`Ia4mmRy% V\ 2xT^ #?-ȀFXhD܈0Vp/Z"Ea݂$X8" yaEF>ฃjzQn4@ٻK.> oDP}?Ìً[2b>Rw4&t)3UrjQ xbp{1{fS_PYQ #=}Uӂ" jC!pW~ Ii?| M-^ dCkN<^}UM>Wo߯Zu&DV#7Ho_fʓ5n*5][ (a/(rYxw?I',]ػ@E!J9!>#.(u8bew)RmGRr$|&g&ofΝ-2h rz.{[xsĽ^q啧|N|7QPܽu~lygՒ)A}ϞxjxUV\1%sFPf qw\]b_^f!JA RΎ8?.eu\&)m+ qqSif/pْKev\yZk9gu-ѧT]So矩pZs8<|e"<:6=+k:}\2eƌyfe8y:K EKƤ{ # *{waB|ݽaux9'?]`xbѤD"F٧_|'@{Mxz(*>A%%H⎭A tz)-=܀Aȧ>g0<π\Bh\"x eԆD"T v< !djldeA >BƽW\QZV" =t#1O5^|yJ֔]wxG23jwK7|قN{Gw~~>@aI.w=y đK (*6 K0^:ŀTÍ/yAGZBB< $vt{z_~'|joNNp?v,0X]Y`@G,YP~kg0#@!l|S Ynbápz<.,8]}\. a r=/LϿI:\z)si'#ͮꔸhј=c+[j.h=%5De؝n.OGs=m7dY&kb_"6R( E ١Y]8\|Ǧ*Hꜿp:=jk ;[T yF̌=Ͽ|d\Kڝ焖4P n${gF"B|םw]{_|*FX n+ū_~F=VD1c'.Q?`u/PNK 2 FAo?C+V֛oψKo|79M.DƮw8=ȴ*Z 5ZC0h뢯]vo4 } ?7m`?4 ,6}ʔir6mp"$TS,錈E^&VK8cEr.h_n{'qG@FF73XBP Qs> I)'f_^nU*]Ԛ." `Veڭ5,4R,W;HK~2k ȧ:Z& y A2" b*Q˥LzhX_4E@h$M=u~D$&H[.ǥz,ȿA3VWUgӘ:/!Dpv5 E߼n9ץJ5P0Ș3QaT\ p qlRC)h`8N=+jтcCso7_vesgj7tbH=`#4z.ΝaB<‡ޤ VT J`QaÉVx$Y/-p MqnQ bC>)\ z{Zr>\[+&QRv 6T;EPIrbR8)zSZ,=5ZE OlcpIY paa\9Ԋ,]3`s@}r8K'pAȠM${8oo-HLI1[|>lOx@_d8Jy-k~}kE&oݱc QCb- @ADB=T(f8Է%ޞ8QbB8$[`w%%(k1xQjYp͘A*&AJ#KUJDPQV^ObnEBb""9 +?qd}yqWB MNKfesj߁뒻v L~=wyE$ u Ctce&xfN \Qv`$me  DuTDv \[;صq4\1,~ fϞH{oߎ Mfq˻'Nx(Df\E|`KG!į~ |aÄ}$^a*ooMH?B㮸grϿ>'oW]}e JRzPhi'<󒓒rԉozG~jvYC` _qJ0`A+ 2 :>#5 ґ [XޫaABQi)@xU3Dצ+`כXa=3Sɵ(5^ eJ2n=*4*q]waR?<݆zHhxrŴ窫JH;ct$YB򔫯ǟ|Џq2{<i> b4 #>! }PHuPZ1Y8w. b`aG-+.m;ǟ~,^ǎm65TkG*$..>j?eg^x-5DQ]L&+jPѣMm` D'%sy9\}?W]qs_uRbҨN|4){(*OdeǢUh~ԉ!zlaߕio>F0pz;~ƙg W\@yM|šuYZ^LHJI ȚoE# (hL%^WUYc7o{߮?[hH,aܭn-Pκ/8n9_|?6H"skaid:>sO&l nZR,m #bn2E\V˅ϕzK)Em۶_Em[AQ@괝:!@\N z6mPr,=)w}kcb_zٖ3iƍ-T}[TTvk '*2o!nbsC!j&1@نƦʦٳw9l ΝL&~sC;׃7ޡub[[TTb ?{^+ S7 |V_6 ^p`$mp`!]_ŧ mNTlV "K # #&p9melPPNxI;)W74b ;Z dC͗!XldŻ: 8`0ȃBdDY`S*!W12\թ?&[$*!`L IAs >t<|a Qhui(@NbcD_QՖf!BCB>R}ivL6zkޓ 6_LL<)!~OUClS(;}V^Y54gL^^>G ޢI sFC}D,8)kSy {L*n!>*ܐR)(Q`,lz%bt Έ 5wu`S6"^$Ҋd &QHHBS4 $B*]b׮рFa$PѪїWct}7db/sIPQi?A*Gzp4߳Oɧ.q5W2f2###^\\YhX.τ.K`䊆6+:A l6$#N5BC|d4>ʓ Ep"D7IferB@n/L*q.*W}ux &BT!% ĥۗsgddw8^HFfvC!0>h?lcCxdlcCh 6V5Tk4㦛n?93rꉠ.--ikkka?HDm3TB!D |Ӆ<D.O@-q ^Ђ 5EDPr$N7* ~'EfNHtP<]&$d ) v0&~rX"M̄mh/=HE> C` sǘؤZe$],yrj @6lÏ8Pim6+d}ZCV8=\5Fr@ Q%@G#qeQ qI7=W D(3[-N氣!1m"; Ds(]P!8zVEM͑!`>>R(l!D>BUP*J2Kʉ鱑0 F++@P @]%F!lߜ/ C!KH@¨G8(:@(D$R=ϋva qk1 Cz1>|BlWGЃm )C!`9P/m1ТPIW?}hb9& C!p@ a 9Ab"ևPH!^pMC?R6C!|L&uEb1RȋVzs>/5pa3f0 C) O'7ѓ4]Wh .]  UЂή`0 _TևOT2! afe"*4YC!a *.'`Zκc0 @]]^1}0A@bp8-/+V*&C!`0q?Av0 "LC%@g;H4P((O"!k; Y3 C\0g4(&HH(D(x "#~ˍ|>l C"HQQQТAqPX$İq] %9DB$&3 ɉ'$ՠrq91W* 'ULl ބAe4''Bl C!p@!@􄐏񁡏Ń|t.`0jaaЗ\0AgVßlo)uj!6kC!8DxRupy>5ؐba0 1B@"ps!3}|x(f.`0&7D;]$7 =Dr"T] 8pO =C!ceH*r*$RJHB$QJ&֞c1Qr C`!."bN( I QTÆ|C!`>PFRp>ўayi/qoC!AY¤Ṝ.t&Q6XhBwIgǨ"l /!wJQV("BUx|q7q8`&McCf0F  lDFFeç)A}R"{G>Zc`2 C `0okkB9V)chH֎( B!b63GI]le3R$]ɓ2Qt*X{~5wg QEu`D6덠:9Vz>ٌа˜8.5o >C!0r RTTdVVTJvDF-E( 79UxY 8B)T(e0H>rvOP _J|`C!`0 !!9$vttǓPj Ry |C!`00^^+n.uvbsi4hUr,; C!0fx@c+lF(EgۡR7RzC!`f2BBBTJ}$r qHSJQ!&X0v%C!๹\llC$+L&3*N<61 C!0V l$\!WXT ~L&D PN A 5:G~cuu $F@ R Ie2 L҄hH\qG L>MM!`$РDZKxKG 8 ?h[ݣb cuu $F<ɌX-Z IТBG,pLbԽ GKxdc`0F j2E8 -d("|lHEAB(gHxe vcgSuiA^w_-Ż>:/ygşNX{_icz3A)b QF,YRٻ;A9N> E v@efwGn }7ټQZRzU֢iٵ3@qŔF]~쬪*ݷ{箝{v)<]6mȴ1Bd.% Pf_# Dڳ?_*e$oyyyYٓi=vF.Kr,K,FrSN>VQ'',6su֚j-[44WTT ʷAh8)tRkd?peVk{l6P9m (j'`ܽcۦ͛N]0N5Y_U^RRtzfA݆^:uTZ٫:GBb,-v#{sg2"&`?UxdDrrrсbt+r!JL QG/DQβ RuLIW]uuh 8559,,0MqDdIJ#}a TQc?$vEa@GGiFh r@so,().hG'q(p6Zkij4SXXufTHBb111ϟ6mz?w)/(lkmP~[ysqg- {PNJI[js}̙3*N)yM99mۆ=@tt غ]{g/LP 15)_2& :]|Qjwl9PRZ\ZWDށ"Kyo/V8i FRܡ|3? |* qˤRFYPJ%3)2İ`m+*-CedLlkKK{Jjzo-/dKЃemxKuŦm::;uf#Ҳ_}w-͵ϳ2(73}O9u )؛>KMMW\qU7|];w/..ں}o1c\nFLLN W,͓Ni1Re38sEdS#-۶nJ9[`w S7.%%2CxYSbcmN>?o¢ʌcNA>aD7˺_/_NZmV,ewx(HkQ5Xx`stw!,.ޚ_0qw?|kvf P(MM\jR?_OY?_Í':w㟿]a6w3N;;`{vocccz9iub\j0Hsmaaa9{323S> 7ڐ~޻{Gn={vvjΟ{w#B M5SRS;:g͚t3!qL}vG_]TLR2/_VYQY[[#8⋯GJ1-q966d (v:dos:ۆ3;!Kzq:% $e ?P} %;.===O.--ݳggII^CCyi龊eeyEEvmٴ~޺q݁]?~O_~[|3O=h^vXbAfሣWgM]z9GfՉgϻr/XG Qu ͳI&%_Gaqֆb&Օ`Q^Yh=_4<]10^!n9{oSLĮݻw㏘,vH+4?/2' fAS\Zb3:,(=.5<;cϗm&?ؽ{t:=08pV4:kSU] Qo]܄\7#2HE=0 }ic=B%R8Gq<"R'jյ!hh1!q鵝r G}8Lń#kJ&[ <꘣@&I,zd '_pbER4N)i1764RiH@`O=-5522g PUYSTDr"z&YΝQ}| FPbZ[5[hE]xep \{)9hٳgdv)]|1Q#w[YOp򱛓HrAu H --V?.1ⱝ>ǃόu M;>jcOd!!smDcC#K.׽gu[V[{Do9wnFׄ$XH꒨7=ls CpZ%/_!l`r٬hya,B͐p|ͷ+yѨ'=#9ȥ7x?q7Ԫ^ѳpY y*'p5O:E`A8n$(*1ӗ%xfs+!m`Q׆l_hGq]n cD$i@5HK~[4 <%7mڄS@V'x)𑖖5MhHDTZª`T|srrFD/g\@Swi{9$<|\)Bh_{ЉΚ5kΜmCmRSfԔi-LgO^h@T4~Ϟ=kHZndFQKة׳g?eN8,na I0As v-Hkim3:&D Af;gh59;7:@\,Qzm!!o_nn_`CO 9Aj4-߸r=0Qևp*8@q(X -T!aǯ9Akҿ޻, ~O*Xx ϝm7Սr溚ꨈ޸t|F!"i`;gD_TR!'p4PL#=N abԔm RS,f[[kyEA(OENo[FTDxĤ@'<"VTZ-NGXVU\rCY :S{uD}A M1Eք!0-1雫+ uonnjjn=Ccӊ+N>4#n. O'#N9\D粪F\e8@8`.ThbQpQdc J{ߣLFPt0lmo bv0#᩸<`#Cɤ0%tvVfsd bҳ 0LPx|1@Ag .t97\ws?Q[״dɒ:3nU98_]57+T uq(93/?x om6#hY}s$.^$~aaaaFge,4G` FNKm^Ih ),ī)cz~7YI'o# YRGek0;X51͛7747iԡrR"WVUnپ_ /xMs#<>O͊!0x8x%DNs!!N hohҤLIݥ|'gL'ϰ3?=3O_?ӉvFii_| aO(qu_(kuƆ. !uvby `jRӱPKo= !$Qa7j IwEKlz~ lR/@$1o)Y3a~ N2DzB%TgO=/,pظys;ߏ/K}d[{SK[[)̇霳^KI D#Uz穮,~àmZ@t\]~EzC)]d TQU O_GzqفR&iYQQZ,,,D?1*Z W+Dt^))qq$D8YU( eNWj(amیb Tvح奰t+kZx'gԛ"B#KF5cI (H41_,,VRtp&Η C7Hbq?TP <_ؚ]XX |kk/q͚uu՗]ra0} y,2=?gϜ?ENɚCUZ;P^s+2* V>< șS@E*%x 6*B# ;Iu t^{Paa:VF,F$m6:0bta.H z8l\&|Pv 2 eH1SR].9mvX\hux)l5妛nil\8hr;w=o*UCx9+aݶ#TnYb;WY䝃AV'aʼ;8QTч{Vz}ws|mwX"ڍ ͍X:]:: ,ĤK}U:_qko2b!o…q?6o6m7_aL9kW`z|>*}` ]'E꾴7uP@HyhķgxRD5P8;~@^}eaF"3P~j $нun{챨tWW^vsm6ٝ^u$ k %9|e"劊 KK >Ⳣ[7{_|믿ZPj5CqtNnKeJ [D.DGۺW^y~s̃p%>Sxo Yb,HV=|TS"TiC4 Oɨ1 _]λlܴ (.p 'p}>o|;,|!1)AEh°_{k~ӦN?rbd@.Br,^'z HG;z iӲN"GB;g>"EdD)SȨB!FA?="N (Fpq}p iB)0?"*, цE]S:BCj#Yq ĽBNxJ,"%p`Q h04|ԏ?zYgTT4E&{e /DX5^}\iiyJJ0y\6 B$)@I$a.`DTEJTB[>;̌ BzAddAf > &/' O( ()}\~?3 O~m沊o*$Ei `P뱁.YtժU‹. cPT~bUdd$$}\ov>{Avjx.]oJGgkӪVVV@||٨Euc ^D|xaZ<CT_пGz]7Ξ3㕗߀ 8_re"c>?9gδx|/VWFEvmzv#fJ,v]gmMU)|iq(1!S}M|σŬ{ͷ UR*GFiBf(svH;?v6F% 7Ԭ~$_|?LwΚ9+%%%qxW]}8\ß-!pX"G @bA ҵW_ֆǃ .8aI[oWXtm{&CTdĎfwJՅ:7?ؿ.zvݺ ܖ$i3+4͕*uRbbLt,^HK?O) ` _11G9QRRA-١Qq zz>x$w޹w!] *0MK"ZAl[h"2.]lG1o޼T@8¢SRB{RMME7m/̚5C\˖b{wma?\eKmojwIy}ʀY_k`Ţg3KD. OcS ,ZuĒH|X" ׬Zu(g̙taPA# ΰĈh+22y{Vn"HO{3njTJ"TJOqшKMKNJJ@9@)II&3#sH0:GI($2  " X[ӲfKHdBV]] ^>JQUUX?!9V+  1(cB/ KVBэAz4JVW׀Rsv툊&9a-u_Ǟa3P*} {#:* {`9sL~R]n,&gv0&!zCs\s=<m޼[KLLR<Äw#RRR YWԓ߿@ $IXL|9ewIbr*$'DuևsGВvbed^s͵IiXk4[KNNMe WjƜ67o%CCBm܊JBB{DHG,Yx4k1+ZڪfN/*.&" ~Jȫ={H3!F9pTOHO*."߄&))%{ƌW^yo}7gi&&hRR< I6.P3{WZp\8~۹9|Od@]y009ѓG7šXɍMr 'Yf͉JedGU_3 :`@9JT!d/0L _Zv%]0!0hm5sƌN ه]Zԁ "DRC-2ZY6lO>䣗ʿ]a:7,"(LR)ߨ7>?UW\ӯN; fﰪ ͔ fx3Ip;g}MKM!$U 7wnFb7Y{vozZuy:} m9m6-0x'7x#@csyvF(1"y9{dk?1'\vr@9qU? <$fE D#<"jjh@{{劕ӧfn%cEsXۓ ;dl>{AY'b62UKJ)J] ~$ - (m6hQ gZz* BCA:)iB4/Q%pJOE}0[kE]:{Μ)7m `#I %򑢅@#oO?+*۰a MFC:>7HFJT?A4Ɨ rTc 9hTWT+($E9"gJ c= 1aB9Z}Czb:H}DTEe5*yݷB( ?,A|>/Ϙ>{ 5|E92K8k/-"bX;k̯>}͆ 0R^cw!0wf&dOFiÊ  av.o@02 kH"GL*bQێ*vi~HwDW#t SZ[CHa+*9I`Xd'3 #czYv1wvJ!,AXP ;b1DTIßN[g'hi>EHFy*Lp;/:G*D% s0|kZIzBא؆?Q~<c!`Lj@`,!EjNPb"\#E E A0jZ`C-2fP.JK@(! 0"8ARX(D9X]$2{lPd` 6o6C! y@JA ը;wm**) ID\{v퐊}[z?N/RKD5DyȰPBI( X6+/%5wAm;5|a;A60C! E!eLfGUU%Qb`# ҜCkːT(|Ј@f1:l&ZTpzlf74r<+a1Q$^_VV^TXwߎ;+LTm~Y+:`k@nrmC$A%5"pV@*!_YvXL\LbR|ZJb洬ٳ/LI11-[/()̝3Iz;ٴA9'A2gRQR2t;mv;F@!u-a_58ܱ>7brLZ-AgD:cVQ ;n'!+e5ebD.pK#q/.R6{ִPPE9> @ ǽj@V Q]&^"Ak^xHE'w`'` 5bb0F?94%ht5)SfGSKiw|(n"R3M-<g}PYB KANl\9G֌!%|e҄OkXfA9n8 zC6! f#HnwBbI%tEGWhyEH:<&ڃY3C`$\*'hNjX"Ġz^Tn޽bg3 Q@ ..KV+"ӹD&';.!S09HE@\.1%c6C!8?> B+]jݢF^'ῒo lD C!01 yc3ѱ3#zØ -㻝.|o8 PE(æT)v1 {(~G1hU񛖮`oF8zv0" B Nc_i_u/;eeR=$L%@[ Nfs=`J%J`E)}вqk:!0h0 glAV#f8N m!#s r:%!1R x!>i`{`wn=g,ܫv''&| 8(|Nxa2lZ,kinV*QP^[S׬MMU-Me%wlP[VVʡ}{j-Xc:]N?(-87}p)u'2%8˅&kv?d<111 dD(bL"O*J]T9I[T\V[ھ{מҲ-m а9a@QewWk RP3(#9DŽb論Q6k{2EAnD@ CbGdI@{g)|"OߺgkcccQ~> pؙڪ*$::66&*$:&6&.1r[dee^izJJȶڱs1ѐn6N^[[ L Z\TzdcH'aaa)s NMIhiiUUXՄB!`5lJ%ܷR)lyPS XְcR!2(!灁@mU{޷ {/8~M՘T_C6/x+LKK%A<ԦMZE!BZ S$ƧddF $IbHo]skw?TJ\AYtRbגĢ;1ԞwQvKd6@.P:Ƅ [Hi{6 Z-i-tw2z 4;ɹ?h (LH]LFau8xcbъT*A ]<BVL˕YYY:ӄlފ~J8$7~*i07 UF1Va<"1xP})ؗe6cfR% Ids#00R{GH$tj5v'TT\AS$SF .ltE r҅ݻ~O?=+kR߹wWSSSE҆IҒ' /ɿk}XxNGvo9S/*,ebbmji1 =I$BoNT  l@bЮ&BJ -*&&$:Ǻy[q񝝝1Xe2)ʈ@?.iݐ XĹUB ,2k@-q8xfHr,nCɔz}'$.qdAC6ѡP ?ۊ+n`ٰă3 p >]PIf;(-WG+OmW6Tuݾ}CK ք$hE{imD(0w7HnPJ6\!Fy{[;2(i3A\h67pdc=s:@pb{pJJN.9PV]`sYma4 6I&4<,Ckǣt]-rnhl=rJNOOomi A迭[lMvAQ[ M@ǛVMLHjT`lxP"[\a3*H@-T6zm˟p UU=Т DkO~EE,VYKϹ5y j˯*l#?ؓ֜hZNh!0XqXHL, s@p/>? Kb3Q4щ!(Q<NtG8!FN|>rJH4Y%CVa- &rj{]s(Dxh݅-IJ  "{Jw[;HA mX+pg>W[w~٩WD'AD&-C`yfK$ Fn.LN%XF pW9v(jJDtNwFb'1WuXwCHH3 @&ÀKM|`/↋a5ODwC f!}];(}!OX-4Z%A=n)o>=hǥ z ͺ"~ =}{bɟtk(q$ b"/m$uoIc/olFq-imqn_$YǼ.:h;\ȚCjkIENDB`}$$If!vh55#v#v:V 6h>+55/ 44 6a}$$If!vh55#v#v:V 6h>+55/ 44 6a}$$If!vh55#v#v:V 6h>+55/ 44 6a}$$If!vh55#v#v:V 6+>+55/ 44 6a}$$If!vh55#v#v:V 6h>+55/ 44 6a}$$If!vh55#v#v:V 6;>+55/ 44 6a$$If!vh55#v#v:V 6>+55/  / 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6a}$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6a}$$If!vh55#v#v:V 6h>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6a}$$If!vh55#v#v:V 6+>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6ay$$If!vh55#v#v:V 6>+55/ 44 6a666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH666666666666666666666666666666666666666666666666666666666666666666<@< NormalCJ_HmH sH tH f@f  Heading 1*$$Z-D1$@&M ]Za$5>*CJ \hX@X  Heading 2$ & F<1$@&56OJQJhR@R  Heading 3$ & F<1$@& OJQJhT@T  Heading 4$ & F<1$@&5OJQJhL@L  Heading 5 & F<1$@&CJhN@N  Heading 6 & F<1$@& 6CJhT@T  Heading 7 & F<1$@&CJOJQJhV@V  Heading 8 & F<1$@&6CJOJQJhZ @Z  Heading 9 & F<1$@&56CJOJQJhDA@D Default Paragraph FontVi@V  Table Normal :V 44 la (k(No List \$@\ Envelope Address!@ &+D/^@ >O> Chapter $1$a$ 5CJh>O> identb12c $1$a$5h:O": Subidentity1$h:O2: Identity $1$a$hHOBH xl24dd[$\$5OJQJ\^JaJHORH Identitycb14 $1$a$ 5CJh4 @b4 Footer  !.)@q. Page Number4@4 Header  !4>@4 #-Title$a$5CJRYR b Document Map-D M OJQJ^J^C@^ bBody Text Indent01$7$8$^`0CJaJX^@X DV Normal (Web)dd[$\$B* CJOJQJph؁,&'BCDEFGHIJKLMNOPQRT]^wxF @"+S  FG[*+rOejs3   6 7 W d d e  , R 3  GbX+`a.    /Qw"#abc|} /@A\hw]nKiR-Sk~-&G; !L!d!!"W"j""""@#G$$`%%%%%&3&R&v&&&&'M'''E(h(((()))))7*S*** ++,,,,,,,,,,,,,,,,,,,,,,,,,,,---@-A-a-w------4.x...../ /K/[/i//////// 0 00P0f000000000000000000 1Q11111112%2P2k22222223333G33 4447595Z55A6B6}66`77#8$8?88 9B9C999o::E;;;;:<<==!=.=/=0=1=E=F===@@@@AAUAABBBBDDDDDDEFmGHIJJJJJJJJJJKKKKKKKKKKKKKKKKKKKKKLL LBLLLLLLLLLLMMMVMWMiMMMMMMMMMMMMN!N"NGNNNNNNNOO(OXOYOiOOOOOOO P PP?P@PbPPPPPPPPPPQQ8QoQpQQQQQQQQQQQRR RCRDRiRRRRRRRRRRRRR,S-S5SSSSSSS#T$T-TsTtT~TTTTTTTUU2UYUZU{UUUUUUU VV>VVVWV_VVVVVVVVVVVVW2W3W;WLWMWUWfWgWWWWWWWX.X/X=XjXkXXXXXXXXYY!Y3Y4Y[YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYZtZZZ,[c[[[\\_k___G`m```aaaaaIbJbKbLbMbNbObPbQbRbSbbbb c'cnXnnofoooo8pppAqqrrrrr*r]\_i_8bGbccccddlisiiippppƁǁցف33333333333333333333333333333333333333,]^x@+G[rOsc f c , R  Gb +  c,,,,,,,,,,,,,,,0001111P222=JYYYIbRbjjW}W}āǁցفc f c   ,,,,,,,,,,,,ցفB;- FR6n w   .0 K[Ff`F,!.(`i'.L ,x(.(T,. ? ] E +#>I M MO 'P T;\ d\ wj] Lq]  `*Bzc rbf  Bg.(l :#q + b`{ X~ Erp^`OJQJ^Jo(  ^ `OJQJ^Jo(o  ^ `OJ QJ ^J o(xx^x`OJQJ^Jo(HH^H`OJQJ^Jo(o^`OJ QJ ^J o(^`OJQJ^Jo(^`OJQJ^Jo(o^`OJ QJ ^J o(@hOJQJ^Jo(.^`.pLp^p`L.@ @ ^@ `.^`.L^`L.^`.^`.PLP^P`L. hh^h`OJ QJ o( hh^h`OJ QJ o( hh^h`OJ QJ o( hh^h`OJQJo(h^`OJ QJ ^J o(h^`OJQJ^Jo(ohpp^p`OJ QJ ^J o(h@ @ ^@ `OJQJ^Jo(h^`OJQJ^Jo(oh^`OJ QJ ^J o(h^`OJQJ^Jo(h^`OJQJ^Jo(ohPP^P`OJ QJ ^J o(^`o()88^8`o()^`o()^`o(()pp^p`o(()  ^ `o(()@ @ ^@ `o(.  ^ `o(.^`o(.hhh^h`OJ QJ o(hHh88^8`OJQJ^Jo(hHoh^`OJ QJ o(hHh  ^ `OJQJo(hHh  ^ `OJQJ^Jo(hHohxx^x`OJ QJ o(hHhHH^H`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hH88^8`o()^`o()^`o()pp^p`o(()  ^ `o(()@ @ ^@ `o(()  ^ `o(.^`o(.xx^x`o(. hh^h`OJQJo(hh^h`OJQJ^Jo( hh^h`OJQJo( hh^h`OJ QJ o( hh^h`OJ QJ o( hh^h`OJQJo(h^`OJQJo(hHhp^p`OJQJ^Jo(hHoh@ ^@ `OJ QJ o(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJ QJ o(hHh^`OJQJo(hHhP^P`OJQJ^Jo(hHoh ^ `OJ QJ o(hH hh^h`OJ QJ o( hh^h`OJ QJ o( hh^h`OJQJo( hh^h`OJQJo(hh^h`o()^`o()88^8`o()^`o(()^`o(()pp^p`o(()  ^ `o(.@ @ ^@ `o(.  ^ `o(. hh^h`OJ QJ o( hh^h`OJQJo(88^8`o()^`o()^`o()pp^p`o(()  ^ `o(()@ @ ^@ `o(()  ^ `o(.^`o(.xx^x`o(. hh^h`OJ QJ o( ^` Chapter ^`^`^`^`^`^`^`^` hh^h`OJQJo( hh^h`OJ QJ o(0^`0o(.^`. L ^ `L.  ^ `.xx^x`.HLH^H`L.^`.^`.L^`L.:#qb`{rbfMOErX~M.0T,.wj]l w] ELq]d\6n+#>IBzc;\?`F,! Bg ,x(K[;-  ``i''P n        ]        n                                  43TIv 2l/Ru'S*k+#-62|2/:30Q4<J<C=Kj1MHUDV=wW%|WVZn\Zf\ fishzkLNEQ6M1bb-mBR 9PFcbBoeJJKKKKKKKKKKKKKKKKKKKKKLL LBLLLLLLLLLLMMMVMWMiMMMMMMMMMMMMN!N"NGNNNNNNNOO(OXOYOiOOOOOOO P PP?P@PbPPPPPPPPPPQQ8QoQpQQQQQQQQQQQRR RCRDRiRRRRRRRRRRRRR,S-S5SSSSSSS#T$T-TsTtT~TTTTTTTUU2UYUZU{UUUUUUU VV>VVVWV_VVVVVVVVVVVVW2W3W;WLWMWUWfWgWWWWWWWX.X/X=XjXkXXXXXXXXYY!Y3Y4Y[YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYف 3@ ؁P@Unknown Gz Times New Roman5Symbol3& z ArialMTimesNewRoman,BoldCTimesNewRomanQTimesNewRoman,Italic5& zaTahomaA& Trebuchet MS?5 z Courier New;Wingdings"1hCC&ZSnBZSnB!4dkk 2QHX?i2 CHAPTER 31College of PharmacyCOMPUTER                         Oh+'0  0 < H T`hpx CHAPTER 31College of PharmacyNormal COMPUTER2Microsoft Office Word@@J@_n@_nZSn՜.+,0 hp  University of FloridaBk'  CHAPTER 31 Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ACDEFGHIKLMNOPQXRoot Entry F`$_nZData '&1TablefWordDocument=SummaryInformation(BDocumentSummaryInformation8JCompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q